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ABSTRACT 
 
The blood-brain barrier (BBB) is an interface between the brain parenchyma and the 
circulating system. This barrier plays a vital role in protecting the CNS by restricting 
free paracellular diffusion of molecules from the systemic circulation. 
Methamphetamine (MA) is a highly addictive psychostimulant and has demonstrated 
neurotoxic properties as well as the ability to compromise the BBB. MA exposure is 
strongly linked with increased oxidative stress which can result in a decrease in the 
integrity of the BBB.  
 
The aim of this study was to investigate in vitro effects of pure and street MA “tik” on 
DNA proliferation and cell cycles in mouse brain endothelial (bEnd5) cells. 
 
Trypan blue was used to determine effects of MA (0.0001M-1mM) on cell viability 
and % cell growth. The Cell Titer Glo® luminescent assay and nonradioactive 
analogue, 5-bromo-2'-deoxyuridine (BrdU) was used to detect ATP and DNA levels, 
respectively. Cell cycles (propidium iodide incorporation) were analysed using flow 
cytometry. Statistical analysis was performed using Wilcoxin Rank Sum Test in 
which P<0.05 was denoted as significant. 
 
Results of this study showed that: 
1. Viability of bEnd5 cells exposed to all selected concentrations of MA were 
unaffected when compared to controls (P>0.05) 
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2. % Cell growth was suppressed by MA exposure at 96hrs in comparison to that 
of controls (P≤0.03). 
3. Cells exposed to MA had significant higher ATP concentrations than control 
cells at 96hrs (P ≤.0.03) 
4. DNA synthesis was markedly suppressed in cells exposed to pure MA and 
street MA sample 4 (P≤0.03), while was similar and higher in cells exposed to 
street MA sample 1 (P=0.39), and street MA sample 2 and 3 (P≤0.04), 
respectively at 96hrs. 
5. bEnd5 cell were arrested between 72 and 96hrs at the G1-S phase. 
In conclusion, this study demonstrated pure and illicit samples of MA obtained from 
forensic police did not affect the viability of bEnd5 cells, however resulted in the 
significant suppression of their cell numbers. This growth inhibition may be due to 
MA-induced cell cycle arrest at the G1-S phase. The study also showed that 
compounds found in the samples of street MA produced results significantly different 
to that of pure MA.  
 
Key words: Blood brain barrier, methamphetamine, viability, ATP, DNA 
proliferation, cell cycle.   
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CHAPTER 1 
 
Introduction 
 
Methamphetamine (MA) is a highly psychostimulant street drug that is addictive and 
toxic to the animal and their neural tissue (Krasnova et al., 2009). The use of MA 
poses a significant health problem as it has become a worldwide challenge with an 
estimated 15 to 16 million users (Krasnova et al., 2009). According to the Medical 
Research Council of South Africa (MRCSA), by 2007, the number of patients 
admitted for treatment reporting MA as their primary or secondary substance of abuse 
had increased by 49% between 2002 to 2006 December. MA was reported as a 
primary drug of abuse and its prevalence was the highest in the Western Cape 
Province (35%) when compared to other provinces in South Africa (SA).  
 
MA causes neuromophological and psychological effects in the brain and also causes 
changes in the morphology of the vascular circulation of the brain; it also affects the 
blood brain barrier (BBB). The BBB is present at the interface between the brain and 
the circulating system (Shinsuke et al., 2009). The anatomical and structural location 
of the BBB is at the brain microvascular endothelial cells (BMEC) of the capillaries, 
of the brain, and epithelial cell surface of the choroid plexus (Dixon et al., 2006). 
Studies showed that MA changes the BBB function by altering the tight junction (TJ) 
proteins between endothelial cells in the central nervous system that restrict the 
passage of solutes (Martins et al., 2011), Yuan et al (2011) study focused on the 
effects of MA have on its neurophysiological effects. Not much has been reported on 
the in vitro effects of MA on the BBB and its components.  
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MA bought at the street for illegal consumption is manufactured in clandestine labs 
and it is not 100% pure. Samples obtained on the street are normally called "tik" in 
the Western Cape province of South Africa. The aim of this study was to investigate 
the in vitro effects of pure and street MA ("tik") on the physiological and functionality 
of the  immortalized mouse brain endothelial (bEnd5) cells as a model of the BBB.  
 
 1.1 Anatomy of the Blood Brain Barrier  
The BBB is present at the interface between the brain parenchyma and the 
intravascular compartment (Shinsuke et al., 2009). This interface between the blood 
and the brain tissue is formed by the brain BMEC of brain capillaries which display a 
unique structure characterized by low permeability and the presence of intercellular 
tight junctions (TJs) and the polarized morphology of BMEC (Kwang., 2006). TJs 
constitute the primary anatomic substrate of the BBB.  The BBB exists because the 
endothelial cells that line the capillaries of the CNS are extensively interconnected by 
TJs at their lateral surface. When compared to other tissues the blood barrier in the 
brain is unique (Nicolas et al., 2007). The endothelium of BBB differ from the 
peripheral endothelium capillaries by having tight intercellular junctions, minimal 
pinocytotic activity and the absence of fenestrations (Winfried et al., 2006). In 
addition the BBB endothelium differs from that of other capillaries because of the 
presence of pericytes within the capillary basement membrane and the astrocyte foot 
processes that ensheath the capillaries (Fig.1.1). Furthermore, the endothelial cells 
comprises of an extremely low quantity of transcytotic vesicles. The endothelial cells 
lining the brain capillaries and the astrocytic endfeet play an essential role in 
maintaining the BBB structure (Nicolas et al., 2007).  
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Figure 1.1. A. The brain blood barrier. B Cross section of a cerebral capillary 
(http://www.docstoc.com/docs/91914042/Blood-brain-barrier). 
 
 
Figure 1.2. The neurovascular unit. A. Electron microscopy (TEM) of rat brain section showing a 
neurovascular unit. B. Confocal microscopy 3D-reconstruction of rat brain section showing part of 
cerebral vascular tree: endothelial cells (green) are surrounding with astrocytes (red), which are 
visualized with von-Willebrand factor and glial ﬁbrillary acidic protein staining respectively (Nicolas 
et al., 2009). 
 
1.1.2 Tight junctions 
Tight junctions (TJs) in the endothelial cell act as a physical barrier forcing most 
molecules to take a transcellular route across the BBB, rather than moving 
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paracellularly through junctions, as in most endothelia (Imola et al., 2011). This 
allows for a greater measure of regulation across the BBB. TJs have been largely 
implicated in both paracellular permeability and in the generation and maintenance of 
the physiological polarity of BMEC (Diamond., 1977). TJs form the morphological 
and functional boundary between the apical and basolateral cell surface domains,  
particularly in the endothelium of brain capillaries. The presence of an uninterrupted 
line of TJs at the cell-cell borders is one of the most important elements of BBB 
phenotype of BMEC. TJs are responsible for the separation of the apical and the 
basoletaral compartments leading to the functional polarization of the cell, and for the 
restriction of the paracellular pathway. The molecular components of TJs can be 
separated into two: transmembrane and cytoplasmic plaque proteins. Transmembrane 
proteins of endothelial TJs include occludin, junctional adhesion molecules and 
members of the claudin family (Imola et al., 2011). On the surface, the molecular 
structure of tight junctions generally appears to be similar in all barrier systems, 
however, there are differences between epithelial and endothelial TJs (Fig.1.2). For 
example, BBB endothelial cells differ from epithelial cells by the intercalation of 
components of adhesion and tight junctions and reveal cadherins along the entire 
intercellular cleft (Schulze et al., 1993). The BBB TJs of mammalian species are 
described as having the highest complexity found in the vasculature of the body. TJs 
are made up of integral proteins (claudins 1 and 5, occludin) and plaque proteins (ZO-
1, ZO-2/3, 7H6 and cingulin) that link the integral TJs proteins to the actin 
cytoskeleton (Fig.1.3), (Imola et al., 2011). 
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1.1.2.1 Occludin and Claudins 
TJs proteins form domains of occluded intercellular clefts, which in freeze-fracture 
studies can be seen to form an intramembrane network of molecular strands. These 
strands appeared as a chain of fusion points; using freeze-fracture histological 
techniques as molecules of TJs transmembrane molecule, occludin (60- kDa protein) 
was discovered first (Imola et al., 2011). The claudins (20- to 27-kDa) TJ molecules, 
which together with occludins seem to complete the task of establishing paracellular 
barrier properties. Both occlidin and claudins are integral membrane proteins that 
share the four transmembrane domains. The claudins are not randomly distributed 
throughout the organs, instead are regulated anatomically and inserted into the 
membrane by mechanisms not completely understood (Wolburg et al., 2002). These 
proteins are now believed to be primarily responsible for permeability restriction.  
 
1.1.2.2 Adhesion molecule structures between BMEC 
Adhesion molecules such as the junctional adhesion molecule family (JAM) and the 
newly discovered molecule endothelial cell-selective adhesion molecule (ESAM) are 
localized at lateral walls of the BMECs as well (Wolburg et al., 2002) (Fig. 1.3). JAM 
at the basal to the TJ strands form desmosomes that provide more solid structural 
support and join the cytoskeletons of two adjacent cells. JAM-1 (formerly JAM) is 
expressed in endothelial and epithelial cells, whereas JAM-2 and JAM-3 (formerly 
VE-JAM) are expressed in most vascular endothelial cells (Wolburg et al., 2002). 
JAMs function as a mediator of leukocyte-endothelial cell interactions and are 
regulators of the  cell physiological polarity. TJs form unbroken intercellular contacts 
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that control solute movement through the paracellular pathway across epithelia (Fig. 
1.3).  
 
1.1.3 Components of the BBB 
The concept that BMEC make up a functional neurovascular unit comes from the 
observation of their interaction in the normal state and their coordinated response to 
injury (Maxime et al., 2008). The highly specialized cerebral BMEC of the BBB 
regulate the entry of circulating substances across the paracellular pathways between 
adjacent cells into the brain by the TJs. In addition, specialized transcellular transport 
is regulated by inherent cellular molecules mechanism (Boveri et al., 2006). There, 
pericytes plays an important role in the regulation of endothelial proliferation. 
Dysfunction of these cells, results in an abnormal vasculogenesis, endothelial 
hyperplasia and increased permeability across the BBB (Imola et al., 2011), as can be 
seen in certain different forms the "end feet" of astrocytes encircle the outside of 
capillary endothelial cells. This endothelial-glial allegiance has an important influence 
on the formation and maintenance of the BBB. Astrocytes (Fig1.2) as the third 
important component of the BBB, covers a crucial part of the endothelial surface. 
These cells are sources of important regulatory factors (Imola et al., 2011). 
 
1.1.4 Development of the Blood-Brain Barrier 
The development of the BBB begins to form during early embryonic development 
(Shadi et al., 2012). The BMEC develop in the embryo from mesodermal cells at 
about 18 days gestation. During embryogenesis, the BBB barrier tightness gradually 
increases throughout development (Shadi et al., 2012). Functionality of the BBB start 
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early in gestation as seen in rodents. During the embryonic development, the brain 
capillaries lose their fenestrae and become smaller and thinner in shape (Engelhard., 
2003), inter-endothelial cell junctions become more widespread and interconnected 
(Imola et al., 2011).  
 
TJs proteins which form the structural basis of BBB and restricts the paracellular 
diffusion of hydrophilic molecules are expressed very early in fetal development, at 
18 weeks of gestation (Virgintino et al., 2004). Therefore, studies aimed at measuring 
the permeability throughout gestation revealed a significant degree of functional 
tightness developing during early to midgestation (Fig1.4) (Shadi et al., 2012). 
Studies by Butt et al, (1990) showed that vessels demonstrated resistances in the 
range of 1100-1500  Ω.cm-2 after birth.  
 
Central hemangioblasts form hematopoietic stem cells and peripheral hemangioblasts 
form angioblasts.  Angioblasts are precursors of mature endothelial cells that migrate 
along with newly formed endothelial cells, after stimulation by the vascular 
endothelial growth factor (VEGF) to form the first primitive vascular plexus. The 
tubules continue to enlarge and grow through a process called vasculogenesis. 
Vasculogenesis is essential for maintaining homeostasis and is tightly regulated by 
pro- and anti-angiogenic agents (Lamalice et al., 2007). Endothelial cells lining blood 
vessels do not complete vasculogenesis on their own, but along with periendothelial 
smooth muscle cells. The vascular smooth muscle cells not only contract, stabilize 
and protect delicate vessels, but also provide homeostasis of the BBB (Gerecht-Nir et 
al., 2004). Migration of capillary endothelial cells is essential in cascade of events that 
are involved in vasculogenesis (Lamalice et al.,  2007). 
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1.1.5 Transport across the BBB 
In the BBB, the BMEC transport nutrients to neurons and clear potentially toxic 
substances from the brain. These TJs prevent the diffusion of materials between 
adjacent endothelial cells, allowing only certain small molecules to pass and are a 
crucial component of the BBB. 
 
 In addition to the barrier function of the BBB it has an important carrier function. 
The transcellular carrier function, of the BMEC is responsible for the transport of 
nutrients to the brain and removal of metabolites (Maxime et al., 2008). P-
glycoprotein (ABCN1) is one of the important carrier transporters, which are able to 
transport different liphophilic drugs out of the BMEC. Certain small lipid-soluble 
molecules and blood gases like oxygen and carbon dioxide diffuse passively across 
the BBB. All the essential polar nutrients like glucose and amino acids require 
specific transport proteins in order to reach the brain (Imola et al, 2011). Glucose is 
the primary energy substrate of the brain, it enters the brain through the help of 
glucose transporter 1 (GLUT-1). At the BBB functional specific transporters such as 
GLUT-1 and organic anion transporting polypeptides (OATPs) are highly expressed 
(Maxime et al., 2008). GLUT-1 is highly enriched in BMEC. 
 
The essential amino acids cannot be synthesized by the brain and, therefore, must be 
supplied in the blood vascular system. They enter the brain as fast as glucose. Amino 
acids are transported into the brain by the leucine-preferring or the L-type transport 
proteins (Maxime et al., 2008). 
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Figure 1.3: Molecular composition of tight and adherens junctions (Wolburg et. al., 2002). 
 
1.1.6 Physiological function of the BBB 
The BBB strictly regulates the exchanges between the blood and brain compartments, 
by preventing the paracellular diffusion of hydrophilic solutes, mediating the active 
transport of nutrients to the brain, flux of hydrophobic molecules and drugs between 
the brain to the blood and regulates the trans-endothelial migration of circulating 
blood cells and pathogens (Kwang., 2006). An intact BBB is of key importance since 
it functions as a selective barrier between the brain and the blood and maintains the 
homeostasis of the brain parenchymal microenvironment (Janigro et al., 1998). 
Understanding the BBB makes it possible to predict whether a compound‟s 
interaction with it is likely to compromise its functionality or whether a compound 
will reach the CNS compartment in significant amounts and is likely to have a direct 
effect on brain cells (Maxime et al., 2008). The permeability of the BBB in 
physiological situations is regulated mainly by astrocyte-derived factors that control 
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both the transport properties of the endothelium and the organizational tightness of the 
TJs in the membrane (Hawkins et al., 2005).   
1.1.7 Role of the BBB in maintaining the homeostasis in the CNS 
It is essential that homeostasis in the BBB is maintained for normal function of the 
CNS. The BBB lets essential metabolites pass from the blood to the CNS but blocks 
most molecules that are greater than 500 daltons, such as hormones, 
neurotransmitters, viruses and bacteria which are consequently prevented from 
crossing the BBB. It also implies that many drugs, which could be used as potential 
treatment for disorders of the CNS, cannot be used (e.g Dopamine cannot pass the 
BBB then L-dopa is utilized, L-dopa for dopamine). The establishment of TJs 
maintain cell polarity, results in a specific distribution pattern of distinct transporters, 
non-selective drug export pumps and receptors on the apical and basolateral plasma 
membranes (Cereijido et al., 1998).  
Transporting of large molecules such as, glucose and amino acid across the BBB, 
both in vivo and in vitro, including single-pass indicator diffusion and cultured 
endothelial cells methods have been studied. Compromised permeability and transport 
properties at the BBB may lead to alterations in cerebrovascular regulatory 
mechanisms of blood flow resulting in disrupted signalling between the BMEC and 
associated cells such as neurons and glial cells (Maxime et al., 2008). The BBB, with 
regard to metabolites has been viewed as a passive system (Maxime et al., 2008).  
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1.1.7.1 Ion homeostasis and BBB 
Proper neuronal function necessitates a highly regulated extracellular environment, in 
which the concentrations of ions such as Na
+
, K
+
, and Ca
2+ 
must be maintained within 
a very narrow range. Control of extracellular K
+
 concentration is of particular 
importantance for the functioning of the brain (Schielik et al., 1990). The active 
uptake of K
+
 into brain cells by the Na
+
/K
+
 exchange pump, which is a membrane-
bound enzyme Na
+
/K
+
-transporting ATPase, is responsible for the maintenance of 
membrane potentials. BMEC with their TJs strictly regulate entry of K
+
 from the 
blood to the extracellular compartment of the brain via the transcellular BMEC 
pathways, despite a definite concentration gradient favoring such movement. Sodium 
ion transporters on the luminal membrane and Na, K-ATPase on the anti-luminal 
membrane account for movement of sodium from the circulation to the brain. Little is 
known about the direct effects of MA on the permeability of bEnd5 cells and how it 
may lead to compromises in regulation of CNS ionic homeostasis.  
 
Figure 1.4. TJ protein complex at the apical side of two adjacent cerebral vascular endothelial cells. 
Intergral proteins such as occludin, claudin, and JAM come together to seal the intercellular gap and 
limit the diffusion of molecules across the endothelium (Shadi et al., 2012).  
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1.2 Cell Cycle  
New endothelial cells necessary to replace cells that die, for tissue growth and repair 
are produced by cell division. Cell growth and division is determined by a successful 
cell cycle which is carefully regulated. The most basic function of the cell cycle is to 
duplicate accurately the vast amount of deoxyribonucleic acid (DNA) in the 
chromosomes and then segregate the copies precisely into two genetically identical 
daughter cells (Bruce et al., 2002). There are two major processes which define 
phases of the cell cycle namely S phase and M phase. DNA duplication occurs during 
S phase, which requires 10–12 hours and occupies about half of the cell-cycle time in 
a typical mammalian cell. S phase of the cell cycle is the most preserved and least 
sensitive to modifications (Clara et al., 2011). After the S phase, chromosome 
segregation and cell division occur in mitosis (M phase), which requires less time 
(±2hr) (Bruce et al., 2002). M phase begins with chromosome condensation, followed 
by the duplication of the DNA strands and the resultant strands are packaged into 
elongated chromosomes. This phase ends with the strands condensing into more 
compact chromosomes required for their segregation (Bruce et al., 2002). Mitosis and 
cytokinesis together define the M phase of the cell cycle, in which the latter refers to 
the division of the mother cell into two daughter cells. These daughter cells are 
genetically identical to each other and to their parent cell. M phase only lasts for about 
10% of the cell cycle. Most cells require more time to grow and double their mass 
proteins and organelles than they require to replicate their DNA and divide. Large 
quantities of energy are required during the S phase. An extra gap phase is inserted in 
most cell cycles to allow more time for growth, G1 phase between M phase and S 
phase and a G2 phase between S phase and mitosis. These two gap phases serve (G1 
and G2) as more than simple time delays to allow cell growth and to build up energy 
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for the next phase. They also provide time for the cell to monitor the internal and 
external environment to ensure that conditions are suitable for division (Bruce et al., 
2007). The preparations are completed before the cell commits itself to the major S 
phase and mitosis. The G1 phase is especially important in this respect. Its length can 
vary greatly depending on external conditions and extracellular signals from other 
cells. If extracellular conditions are unfavorable, cells delay progress through G1 and 
may even enter a specialized resting state known as G0 (G zero), in which they can 
remain for days, weeks, or even years before resuming proliferation. Indeed, many 
cells remain permanently in G0 until they or the organism dies (e.g. neural and muscle 
cells) (Bruce et al., 2007). If extracellular conditions are favorable and signals to grow 
and divide are present, cells in early G1 or G0 progress through a commitment point 
near the end of G1. After passing this point, cells are committed to DNA replication, 
even if the extracellular signals that stimulate cell growth and division are removed.  
Therefore, the eukaryotic cell cycle is usually divided into four sequential phases: G1, 
S, G2, and M where G1, S, and G2 are referred as interphase. In a typical human cell 
proliferating in culture, interphase might occupy 23 hours of a 24 hour cycle, with ±1 
hour for M phase (fig. 1.5).  
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Figure 1.5. The division of the cell cycle ( http://home.earthlink.net) 
 
1.2.1 Cell cycle proliferation and Apoptosis 
Regulation of cell numbers are determined by a complex balance of cell death and cell 
proliferation. Apoptosis is a genetically controlled response by which eukaryotic cells 
undergo programmed cell death (Vermeulen et al., 2003). This phenomenon plays a 
major role in developmental pathway and provides a homeostatic balance of cell 
populations. Apoptosis and proliferation act in tandem. Cell cycle or apoptosis is 
likely to be controlled by more than one signal. These signals are necessary to ensure 
a proper cellular response (Vermeulen et al., 2003). For a tissue to maintain 
homeostasis, it is dependent on the perfect balance between cell proliferation and 
apoptosis. A link between cell cycle and apoptosis may be supposed from the fact that 
a number of similar morphological features exist between mitosis and apoptosis, 
including substrate detachment, cell rounding, cell shrinkage and chromatin 
condensation (Vermeulen et al., 2003). Eukaryotic cells have a complex network of 
regulatory proteins, which controls and that governs progression through the cell 
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cycle (Bruce et al., 2007). Some of proteins involved in cell cycle and apoptotic 
pathways include: c-Myc and p53 (Vermeulen et al., 2003). c-Myc is a nuclear 
phosphoprotein that functions as a transcription factor stimulating both cell cycle 
progression and apoptosis. c-Myc has a critical role in normal cell cycle progression, 
especially during transition from G1 to S phase (Vermeulen et al., 2003). p53 is 
widely recognized as a protein functioning during the cell cycle and apoptosis. p53 
regulates these processes by transactivating genes involved in different cellular 
functions, but p53 also activates transcription-independent mechanisms of apoptosis. 
Different components (c-Myc and p53) common to cell death and the cell 
proliferation have been identified and provide a rationale for linking cell cycle and 
apoptosis.  
1.2.2 ATP and Cell Cycle 
Energy source of a cell is equal connected to the ATP concentration. Mitochondrial 
function and its energy source are intimately connected to the cell cycle. Division of a 
cell is dependent on the relationship between the structures needed to duplicate and 
energy required for these process. Therefore, the role of energy production during the 
cell cycle is dependent on the understanding of its regulation. Mitochondria is defined 
as the power house of a cell, its function involves generating ATP required to power 
different complex cellular processes such as growth and differentiation (Wallace., 
2005). When a cell is given the energy necessary to replicate the entire content, 
including DNA as well as organelle and membrane components, cells must be able to 
check if there are nutrients to complete these processes (Wallace., 2005). The cell 
division is unidirectional and DNA is replicated only once per cycle. Mitochondrial 
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energy production presents the dividing cell with a challenge in reducing ROS 
product formation normally via the Krebs cycle in the mitochondria (Wallace., 2005).  
Dividing cells can generate energy via pentose phosphate pathway (PPP), with the 
intermediate products of the NADP molecule. NADPH is the primary co-enzyme 
involved in innate cellular antioxidant mechanisms that which prevents oxidative 
damage, as well as an essential cofactor in the reductive biosynthesis of fatty acids, 
nucleotides and amino acids (Wallace., 2005). 
If available nutrients do not meet the  metabolic energy requirements, then instead of 
a cell expending energy on division, cell division is arrested. A mitochondrial 
checkpoint exists in late G1, where low ATP concentration prompt the activation of 
an AMPK–p53–cyclin E-dependent pathway that presumably arrests energetically 
impaired cells instead of committing to cell division (Finke et al., 2009).  
1.3  What is Methamphetamine?  
 
MA and related analogs of neuroamphetamines known as „speed‟, „ice‟, „eve‟, or 
„ecstasy‟ have become popular as recreational drugs of abuse (Imam et al, 2001). The 
use of the illicit psychostimulant MA, has become a worldwide health problem with 
an estimated 15 to 16 million users in the world (Granado at el, 2011). Between 1992 
and 2001 it was reported in the United States (in over 33 states) about a 100% 
increase in admissions to treatment centers for abuse of MA (Masato et al., 2002). 
This exceeds the number of heroine and cocaine abusers, making MA the second most 
widely abused drug after cannabis (Krasnova et al., 2009). MA is  one of the most 
addictive street drugs with a variety of forms and street names. A study performed by 
the Medical Research Council (MRC) in South Africa (S.A.) showed that the use of 
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MA was escalating (Plüddemann et al., 2007). By 2007, the number of patients 
admitted for treatment reporting MA as their primary or secondary substance of abuse 
had increased by 49% (Plüddemann et al., 2007). Data from South African 
Community Epidemiology Network on Drug Use (SACENDU) indicated that, use of 
MA as a primary drug of abuse was the highest in the Western Cape Province (35%) 
when compared to other S.A. provinces. It has been suggested that MA is far more 
dangerous than any other drug in S.A. because it makes the user more prone to 
violence (Plüddemann et al., 2007). Krasnova and coworkers (2009) hypothesised 
that the inexpensive production of this drug, its low cost and long duration of action 
added to its wide spread prevalence and appeal.  
 
1.3.1 History of Methamphetamine 
MA was first produced by Dr. Nagayoshi Nagiai of Tokyo Imperial University in 
1888 by reducing ephedrine with hydriodic acid & Red Phosphorus ((HI/red P), 
(Fig1.6) (Ogata., 1919). The term “methamphetamine” was derived from the groups 
in its chemical structure; methyl alpha-methylphenylethylamine. In the early 1900s 
western civilization discovered the benefits of ephedrine and pseuodephedrine as 
brochodilators and nasal decongestants. The "ma huang" plant was used as the only 
source of MA. There was a fear that the "ma huang" plant, which is a source for the 
herb ephedra, would be depleted due to the rate at which ephedrine was being 
consumed (Ogata., 1919). In 1927, a USA  researcher Gordon Alles discovered that 
amphetamine worked as a substitute for ephedrine. Amphetamine then started being 
synthesized as a substitute for ma huang (a local name for MA in Japan) (Emad., 
1929). It was marketed in 1932 as “benzedrine” as an over-the-counter inhaler to treat 
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nasal congestion. The stimulant effect of amphetamine was first recognized in 1935 
and was used to treat narcolepsy. The first published report of amphetamine addiction 
and psychosis was in 1938 (Person et al., 2005). In the 1940s, the Food and Drug 
Administration (FDA) approved MA for medicinal purposes, (Person et al., 2005). 
Amphetamine and MA were categorized as Schedule II drugs in 1971. In Canada ,it 
became illegal to produce MA for personal and most medical purposes in the mid 
1980s, with legislation following in just a few years later, and within a decade there 
were five specific laws that dealt with MA use, production, or distribution within the 
United States alone (Person et al., 2005). The first illegal HI/Red Phosphorus lab 
seized by the Drug Enforcement Administration (DEA) in California was in 1987. A 
common method of illicit MA manufacture utilizes an alkali metal, typically lithium, 
and liquid ammonia to chemically reduce ephedrine or pseudoephedrine to form 
methamphetamine (Person et al., 2005). MA was synthesized from methylamine and 
phenyl-2-propoanone by another Japanese researcher, A. Ogata in 1919 (Person et al., 
2005).   
 
Figure 1.6 . Synthesis of methamphetamine by Emde and Nagai -Moscow method (Jae et al., 2006). 
 
 
 
 
 
19 
 
1.3.2 Chemistry and Methods of Manufacturing MA 
MA production requires very basic laboratory apparatus and it is for this reason that it 
can easily be synthesised (Syed et al., 2001). MA is an amphetamine derivative. 
Amphetamine is an shorten nomenclature from Masato, the drug's older name„α-
methylphenethylamine‟ which is an older description of the prototypical compound of 
which methamphetamine (methylamphetamine, metamfetamine, N-methyl-1-
phenylpropan-2-amine) is the N-methyl derivative (Syed et al., 2001). 
 
There are different methods used in the illegal synthesis of MA from ephedrine 
compounds. The two-step reduction via chloroephedrine („„Emde‟‟ method) and the 
direct reduction with hydriodic acid and red phosphorus („„Nagai‟‟ method) are the 
most commonly used techniques (Jae et al., 2006). In addition, to these methods 
reduction of ephedrine with iodine, red phosphorus and water („„Moscow‟‟ method) is 
another method that is used for the illicit manufacturing of psychostimulants like MA 
(Fig.1.6) (Jae et al., 2006).   
Figure 1.7. Most common synthesis routes of clandestinely manufactured methamphetamine ( Remberg 
et al., 1999).  
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Current methods known as Iodine/Red P or Lithium/Ammonia methods use 
pseudoephedrine and became popular as other chemicals became illegal (Fig. 1.7).  
The hydroxyl group when using the Iodine/Red P of ephedrine is more reactive than 
the aromatic ring, while excess alkali metal and the presence of a proton source allow 
the formation of a cyclohexadiene byproduct not found in samples of MA produced 
from other manufacturing methods (Person et al., 2005). Illegal manufacturing mainly 
produces MA from pseudoephedrine 2, extracted from commercial cold and flu 
medications (Matthew et al., 2009). MA is commonly synthesized from either 
ephedrine/ pseudoephedrine or phenyl-2-propanone (Fig.1.8) (Gabrielle et al., 2010). 
Hypophosphorous acid method is also one of the commonly used methods to convert 
ephedrine 3 or pseudoephedrine 2 and subsequence to MA (Matthew et al., 2009). 
When MA is manufactured from ephedrine/pseudoephedrine, the carbon and nitrogen 
structure of the product is the same as that of the precursor. The only atom change is 
the replacement of the ephedrine hydroxyl group with a hydrogen atom (Matthew, et 
al., 2009). The actions of ephedrine and pseudoephedrine, and in particular their 
hydrochloride salts, with iodine and hypophosphorous acid result in the formation of 
MA (fig. 1.9) (Matthew et al., 2009).  
 
Figure 1.8. Biotransformation of benzaldehyde to l-PAC leading to methamphetamine (Gabrielle et al., 
2010). 
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1.3.3 Illegal synthesis of MA 
The main supply of illegal MA is from back yard laboratories (Matthew et al., 2009). 
In the subsequent twenty years, the ephedrine as new form of MA was discovered, 
such as crystal MA (Fig1.9). The final product of illegal MA manufactured typically 
contains impurities. Analysis of the impurities provides valuable information about 
the conditions and the chemicals used in the production of the illicit MA (Jae et al., 
2006). Gas chromatography–mass spectrometry (GC–MS) is a method commonly 
used in forensics for detecting these impurities. This particular method is used 
because it can separate the complex mixtures and detect trace amounts of compounds. 
The mass spectrum provides a highly specific„fingerprint‟ of the compounds detected 
that can be used to help identify them by MS library database matching (Matthew et 
al., 2009). GC–MS was instrumental in understanding the production of MA 
fermentation „broth‟ in which benzaldehyde 4 and more interestingly, l-PAC 5, a 
known precursor of ephedrine 3 and pseudoephedrine 2 were precursors of MA 
(Matthew et al., 2009). It is easy to see that the existence of these three compounds in 
a sample of MA during forensic analysis would be indicative that MA manufacture 
started with the biotransformation of benzaldehyde (Matthew et al., 2009). Other key 
components in MA production, such as anhydrous ammonia (AA), widely available in 
agriculture, is also used forensically for identification of the MA source by illicit 
production (Bloom et al., 2008).  
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Figure 1.9. Crystal structure of MA (http://www.rehabclinic.org.uk/facts-about-crystal-meth) 
 
1.3.4  Route of administration of MA 
Various methods of MA administration are used of which the most common methods 
are inhalation via smoking, snorting, injection, or taken orally. Intravenous (iv) 
injection or smoking of the active form of MA are the preferred routes of 
administration by many drug abusers. This is because the onset of pharmacologic 
effects is much more rapid and intense than when MA is taken orally or by other 
nonparenteral routes of administration (Hall et al., 1996).  However, smoking MA, 
which leads to very fast uptake of the drug in the brain, has become more common in 
recent years, amplifying MA's addiction potential and adverse health consequences. 
MA most often is used in a "binge and crash" pattern. MA can produce psychosis if 
used at a higher dose by typically illicit users (≥50mg) (Howard et al., 2008). MA has 
a much longer duration of action than cocaine and a larger percentage of the drug 
remains unmetabolized in the body, which prolongs the stimulant effects (Howard et 
al., 2008). MA also increases the release of dopamine, leading to much higher 
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concentrations in the synapse, which can be toxic if they are left in high content (Hall 
et al., 1996).  
  
1.3.5 Metabolism of MA 
The liver is the major organ of metabolism in the body. It prepares substances for 
excretion. Most substances that enter the body need to be metabolized in order to 
decrease their toxicity to the body, because if they are left in high concentration they 
can be toxic. The common chemical reactions in the liver such as aromatic 
hydroxylation, aliphatic hydroxylation, oxidative N-dealkylation, S-oxidation, 
reduction and hydrolysis are the mechanisms that metabolize drugs, thus facilitating 
their elimination through the kidneys.  It is important to understand the metabolic fate 
of a drug in order to analyze metabolites in biological samples such as blood, urine 
and feces (Kanamoria et al., 2005).  
 
Figure 1.10. Summary of the metabolic pathway of methamphetamine (MA) in the rat liver (Caldwell 
et al., 1972). 
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Caldwell et al. (1972), reported that human subjects receiving 20mg of the drug orally 
resulted in about 90% of the metabolised and non-metabolised MA being excreted in 
the urine within 4 days. During the first day of examination for metabolites, the main 
metabolites were the unchanged drug (22% of the dose) and 4-
hydroxymethamphetamine (15%). Minor metabolites were hippuric acid, 
norephedrine, 4-hydroxyamphetamine, 4-hydroxynorephedrine and an acid-labile 
precursor of benzyl methyl ketone (Caldwell et a.l, 1972). At day 2 the main 
metabolites in the urine were 4-hydroxymethamphetamine (31% of dose), 4-
hydroxynorephedrine (16%) and unchanged drug (11%). Minor metabolites were 
amphetamine, 4-hydroxyamphetamine and benzoic acid. Generally, in humans the 
main metabolite in urine is the unchanged drug, amounting to between 18 and 27% of 
the dose. In addition seven other metabolites were also found: 4-
hydroxymethamphetamine (15%), hippuric acid (5%), amphetamine (2-3%) 
norephedrine (2%), 4-hydroxynorephedrine (1-2%), 4-hydroxyamphetamine (1 %) 
and a precursor of benzyl methyl ketone (about 1% of the dose in 24h). In addition to 
these, an unknown amine (about 1-2 %) and acid (1-3 %) were also detected. MA 
metabolism in the body could be expected to undergo at least three initial metabolic 
reactions, namely N-demethylation, aromatic hydroxylation and aliphatic 
hydroxylation at the methylene group next to the benzene ring (Caldwell et al, 1972) . 
It appears that the primary metabolic reactions are aromatic hydroxylation and N-
demethylation and that 'p-hydroxylation' may only occur as a secondary reaction, 
since only norephedrine (2- amino-1-phenylpropan-1-ol; VII), but not ephedrine (2-
methylamino-1-phenylpropan-1-ol), derivatives were found (Caldwell et al., 1972).  
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There are marked differences in the metabolism of MA in different species. The main 
reaction in the rat was aromatic hydroxylation, in the guinea pig demethylation and 
deamination, whereas in man much of the drug, possibly one-half, was excreted 
unchanged. In rats, about one-tenth of the dose is excreted unchanged and some 3% 
appears as amphetamine. The main metabolites are the phenols, 4-
hydroxymethamphetamine (31%), 4-hydroxynorephedrine (16%) and 4-
hydroxyamphetamine (6%). MA is mainly metabolized through p-hydroxylation, β-
hydroxylation, N-demethylation and deamination in rats (Fig. 1.10) (Caldwell et al., 
1972).  
 
The analysis and interpretation of illegal MA derivatives in the blood is a challenging 
process made difficult by a number of factors. One of the complications comes from 
determination of the origin of MA in a sample because of possible impurities (Cody, 
1993). There are fourteen different metabolite precursors of MA. The main precursors 
are amphetaminil, benzphatamine, clobenzorex, mefenorex, mesocarb and 
prenlymine.  Prescription MA is available only as the d-enatiomer, therefore the 
presence of both origins could not come from use of prescription MA. knowing origin 
of the MA used, may therefore indicate illicit or legitimate medicinal use (Cody, 
1993).  
 
1.3.6  Psychosomatic effects of MA 
The illicit use of MA has had harmful social and public health consequences (Masato 
et al., 2002). MA effects include sensorial arousal, reduced fatigue, euphoria, positive 
mood, accelerated heart rate, elevated blood pressure, pupil dilation, increased 
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temperature, reduced appetite, and short-term improvement in cognitive domains, 
including sustained attention. Its abuse is associated with a number of negative 
consequences in humans, particularly anxiety. Cardiovascular and subjective effects 
appear to increase dose-dependently. It has been reported that MA-associated 
fatalities arise most commonly from multiple vascular congestion, pulmonary 
oedema, pulmonary heart congestion, cerebrovascular haemorrhage, ventricular 
fibrillation, acute cardiac failure or hyperpyrexia (Howard et al., 2008). Its 
hypertensive effects can produce a number of acute and chronic cardiovascular 
complications. Continual use may induce neurotoxicity, associated with prolonged 
psychiatric symptoms, cognitive impairment and an increased risk of developing 
Parkinson‟s disease (Howard et al., 2008). It was observed that this neurotoxic drug 
causes cell death both in vitro and in vivo at certain concentrations (Deng et al., 
2002). Its inconspicuously high abuse potential is owed primarily to its strong 
euphoric properties. Although the acute effects of recreational drugs are known, 
mechanisms resulting in the long-term consequences and possible neurotoxicities 
remain unclear (Yamamoto et al., 2010). 
1.3.7  Morphological effects of MA in the brain 
MA may cause long-term neural damage in humans, with concomitant deleterious 
effects on cognitive processes such as memory and attention (Syed et al., 2001). A 
neuropsychological consequence of MA abuse is cognitive impairment, with working 
memory deficits remaining long after withdrawal (Asanumaa et al., 2002). It is 
reported that MA may compromise the CNS because of its ability to alter the 
permeability of the BBB as a results of it being structurally similar to amphetamine 
and the neurotransmitter dopamine (Asanumaa et al., 2002). This drug produces 
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damage to monoaminergic systems in the brain (Asanumaa et al., 2002, Deng et al, 
2002). Functional imaging studies (Genca et al., 2003) in chronic MA users suggested 
that this agent may affect the white matter. It is also known to cause neuropsychiatric 
complications including psychosis, strokes, coma and death (Zhoua et al., 2004). The 
degenerative processes in the central nervous system are thought to occur through 
either necrosis or apoptosis (Zhoua et al., 2004).  
 
1.4  Mechanism of action of Methamphetamine  
MA is an indirect agonist at DA, NE and serotonin receptors, due to their structural 
similarity. The MA substitutes for these monoamines at membrane-bound 
transporters, namely the dopamine transporter (DAT), noradrenaline transporter 
(NET), serotonin transporter (SERT) and vesicular monoamine transporter-2 (VMAT-
2) (Hall et al., 1996). In vitro studies indicate that MA is twice as potent at releasing 
noradrenaline when compared to dopamine, and its effect is 60-fold greater with 
respect to noradrenaline release than serotonin release. MA entering the brain 
parenchyma causes the release of the neurotransmitters DA, NE and serotonin in the 
central nervous systems (Fig.1.11). MA causes the release of monoamines that result 
in long-lasting neurotoxic damage to monoaminergic systems (Thiriet., 2001). 
Although the mechanisms of MA neurotoxicity at cellular and molecular levels 
remains to be fully clarified, the accumulated evidence indicates that excessive 
dopamine  and glutamate  release as well as the participation of oxygen-based radicals  
of nitric oxide may play a crucial role (Asanumaa et al., 2002). Because MA-induced 
toxicity appears to involve interaction of reactive substances and since these 
compounds can cause neuronal death via apoptotic processes, it is possible that 
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apoptosis may occur after administration of MA doses via damage to monoaminergic 
systems (Deng et al., 2000). The accumulated evidence indicates that reactive oxygen 
species (ROS) are important mediators of the MA-induced neurotoxicity especially in 
dopamine (DA) systems (Asanumaa et al., 2002). Asanumaa et al. (2002) reported 
that MA induced dopaminergic neurotoxicity which was attenuated in p53-knockout 
(KO) mice, demonstrating that p53 plays an important role in MA-induced 
neurotoxicity. Further research data suggest that MA might cause its neurotoxic 
effects via the production of free radicals and secondary effects in the expression of 
genes known to be involved in apoptosis (Imam, et al, 2001). It is reported that MA-
induced release of DA from vesicles to cytosolic and extracellular space, result in free 
radical formation (Deng et al, 2002). Other reports indicate that MA cytotoxicity 
involves the "mitochondrial death pathway" in a dopamine independent manner in 
both in vivo and in vitro models (Genca et al., 2003). MA induces both acute and 
chronic neurotoxic changes in dopaminergic and serotonergic neurons (Chang et al., 
2007). It has also been observed clinically, that chronic MA abuse is associated with 
persistent neurotoxicity and in some individuals the MA development causes changes 
to neural system of the CNS even years after stopping the use of a drug (Chang et al., 
2007).  
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Figure 1.11. Release of dopamine neurotransmitters in the presence of methamphetamine. MA is taken 
up by the plasma membrane dopamine active transports (DAT) in a manner inhibited by the uptake 
blocker nomifensine. Once inside the neuron, MA promotes DA release from synaptic vesicles. MA 
inhibits monoamine oxidase resulting in additional increases in cytosolic DA (Chang et al., 2007). 
 
MA contributes to CNS inflammation by stimulating increased release or activation of 
matrix degrading proteinases, which would lead to the breakdown of the BBB and the 
influx of inflammatory cytokines, chemokines and macrophages into the brain (Chang 
et al., 2007). Syed et al., (2001) performed an In vivo study in rodents and non-human 
primates which demonstrated significant activation of astroglia, microglia and 
mediators of inflammation including prostaglandins, cytokines, interleukin, 
neurotrophic factors and ROS in response to MA administration. These changes may 
be responsible for cellular damage of the BBB leading to increased metabolic 
demands on these vulnerable regions. Cognitive impairment or deficits have been 
reported in individuals actively using MA, as well as during early and prolonged 
periods of abstinence. MA has higher lipid solubility than the unsubstituted 
amphetamine, and thus larger amounts of the drug can rapidly and efficiently cross 
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the BBB (Syed et al., 2001). The methyl group makes the drug even more effective by 
facilitating its penetration into the central nervous system (Bloom et al., 2008).  
 
1.4.1 Methamphetamine and the Cell Cycle 
With evidence clearly showing that MA causes neuron cell death in monoaminergic 
terminals and nonmonoaminergic cells and that MA treatment results in oxidative 
damage to lipids, proteins, and DNA in various regions of the brains, administration 
of antioxidants, such as ascorbic acid, vitamin E, or baicalein alleviates MA-induced 
damage (Wu et al., 2007). Studies revealed increasing evidence that MA-induced 
neurodegeneration to be associated with mitochondria-dependent apoptosis (Wu et 
al., 2007). MA is a cationic lipophilic molecule that can diffuse into mitochondria and 
be retained by these organelles (Davidson et al., 2001).  An accumulation of 
positively charged molecules in the mitochondria would in due course result in 
dissipation of the electrochemical gradient established by oxidative phosphorylation, 
and inhibit ATP synthesis (Wilson et al., 1996). In addition, administration of MA to 
mice has been shown to cause an increase in pro-death proteins (BAX, BAD, and 
BID) but a decrease in anti-apoptotic Bcl-2-related proteins (Bcl-2 and Bcl-XL) 
(Jayanthi et al., 2001). These proteins are known to interact in the mitochondrial 
membrane, and therefore, the MA-induced alterations in these protein contents have 
been suggested to form channels which result a in potential loss across mitochondrial 
membrane, and additionally allows cytochrome c release. This suggests that 
mitochondrial damage may contribute to MA-induced neurotoxicity (Chi-Wei Wu et 
al., 2007). MA induces neurodegeneration through damage and apoptosis of 
dopaminergic nerve terminals and striatal cells, presumably via cross-talk between the 
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endoplasmic reticulum (ER) and mitochondria-dependent death cascades (Tian et al., 
2009).  
In rodents it has been suggested that MA induced apoptosis of striatal glutamic acid 
decarboxylase-containing neurons by causing ER stress and activate mitochondrial 
death pathways (Tian et al., 2009). Many studies have shown that the process of cell 
death induced by MA involve multiple processes including mitochondrial 
dysfunction. MA-induced apoptosis is a relatively recent discovery (Tian et al., 2009). 
MA significantly increase apoptosis in animals after long access to MA for self-
administration (Clara et al., 2011).  
 
Scrutiny of the literature indicate that most research that has been done in the BBB 
has focused on the neurons but not much has been reported on the in vitro effects of 
MA on the endothelial cell of the BBB components. This study will provide insight 
on how MA affects the BBB. 
 
The next chapter (2) describes the methods that were used in this study, while chapter 
3 reports on the results of this study. Chapter 4 is dedicated to the discussion of the 
results and conclusion with the main outcomes of this study.  
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CHAPTER 2 
 
2. Materials and Methods 
 
2.1 Reagents  
 
Methamphetamine (MA) (Cas No: 51-57-0) was purchased from Sigma-Aldrich, 
South Africa (S.A). Street MA samples were obtained from the South African Police 
Department (SAPD) Forensics Laboratory (Kuils River, Western Cape). The street 
MA samples were shown to have 98% purity according to HPLC analysis. For cell 
cycle analysis propidium iodide (PI), (Cas No: 255535-16-4) and RNASE (Cat. No: 
12091-039) purchased from Sigma-Aldrich, S.A. were used. The Cell Titer-Glo 
Luminescent Cell Viability Assay (Cat. No. G-7580) for ATP concentration 
determination was purchased from Anatech (Promega), S.A. DNA synthesis, cell 
proliferation ELISA (chemiluminescent) (Cat. No. 11669915001) was purchased from 
Roche, S.A. The sample number for all the assays performed was in duplicate. MA 
which is water soluble, was added to media after weighing the appropriate amount 
and added to other cell culture media.  
 
2.2 Analysis of street MA samples using Gas Chromatography  
 
A coupled gas chromatography is an analytical comparative technique where 
compounds in the gas phase are separated and their characteristic pattern profile (mass 
spectrum) of the separated compounds are obtained. Gas chromatographic analysis 
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was carried out on the Agilent 7890A coupled with Agilent 5975C VL MSD (mass 
selective detector) with triple axis detector. Using an Agilent 7693 Autosampler, 1µl 
samples was injected under splitless mode through a capillary column (30m X 
0.25mm X 0.25µm film thickness). Helium was used as a carrier gas at a flow rate of 
1ml/min; and inlet temperature was set at 250ºC. The oven temperature was 
programmed to run the samples: initial temperature 50ºC/min; followed by an 
increase of 10ºC/min to 300ºC, and held for ten minutes. The injector and detector 
temperature was set at 240ºC and 300ºC respectively. For every sample tested a 
standard sample containing pure MA was also analysed (Fig 2.1-2.4).  
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Figure 2.1. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 8.69 
min. B) total ion chromatogram of methamphetamine analysed standard using MS for street MA 
sample 1.  
 
 
8.69 
 
 
 
 
34 
 
R
el
at
iv
e 
qu
an
tit
y 
R
el
at
iv
e 
qu
an
tit
y 
Time (Min)
Relative molecular mass 
A
B
 
Figure 2.2. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.62min. B) total ion chromatogram of methamphetamine analysed standard using MS for street MA 
sample 2.  
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Figure 2.3. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.65min. B) total ion chromatogram of methamphetamine analysed standard using MS for street MA 
sample 3. 
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Figure 2.4. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.33min. B) total ion chromatogram of methamphetamine analysed standard using MS for street MA 
sample 4. 
 
2.3 Cell Culture 
Immortalised mouse brain endothelial (bEnd5) cells, (Cat. No. 96091930) purchased 
from Highveld Biologicals was cultured in Delbecco's modified eagle medium 
(DMEM), (Lonza S.A.), supplemented with 10% Fetal bovine serum (FBS), (Gibco 
S.A.), and 1% penicillin/streptomycin (Sigma S.A.), 1% l-pyruvate, (Gibco S.A.), 1% 
non-essential amino acids, (Lonza S.A.). Cells were maintained and incubated in a 
humidified cell culture incubator at 37°C, with 5% CO2. Cell passages used for all 
analysis ranged between P18 and P40.  
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2.4 Trypan Blue Viability Assays 
Trypan blue is taken up by damaged or dead cells due to cell membrane disruption.  
When cells are viewed under the light microscope, they will appear blue if 
compromised. Undamaged will be clear when viewed under microscope. bEnd5 cells 
were seeded at 2x10
4
 cells per 35mm petri-dish in supplemented DMEM. After 24 
hours, the media was removed and cells were incubated with selected concentrations 
of 0.0001mM, 0.001mM, 0.01mM, 0.1mM and 1mM pure MA and street MA 
samples. Controls cells were exposed to supplemented  media only. Cells were 
trypsinated at the selected time intervals of 24, 48, 72 and 96hrs. Media aspirated 
prior to the addition of trypsin- Ethylenediaminetetraacetic acid (EDTA), (White Sci, 
S.A.) was also collected and transferred to designated tubes. Cell viability was 
determined using the cell suspension, trypan blue and DMEM at a 1:3:6 ratio, 
respectively. Viable and non-viable cells were counted using a phase contrast 
microscope.  
% cell growth was also determined comparing the live cell population counted of the 
experimental group with those of the controls.  
 
 
2.5 ATP Concentration Analysis 
The luminescent cell viability assay can be used  to determine the number of viable 
cells in culture based on quantitation of the ATP present, which is indicative of the 
presence of metabolically active cells. The amount of ATP is directly proportional to 
the number of cells present in culture.  
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2x10
3
 bEnd5 cells were seeded in 100μl supplemented DMEM culture medium per 
well in opaque-walled 96-well, white microtiter plates and incubated for 24hrs. 
subsequently the media was then removed and incubated with concentrations of 
0.0001mM, 0.0001mM, 0.01mM, 0.1mM and 1mM of pure MA and street MA for 
24, 48, 72 and 96hrs. Wells containing medium without cells were prepared in order 
to obtain a value for background luminescence, while control wells contained cells 
cultured in supplemented media only. Post incubation times, microtiter plates and its 
contents were allowed to equilibrate at RT for approximately 30min and a volume of 
reconstituted CellTiter-Glo Reagent (prepared as directed by the assay kit protocol) 
equal to the volume of cell culture medium was added to each well. The well contents 
were gently agitated for 2min on an orbital shaker to induce cell lysis. The microtiter 
plates were then incubated for an additional 10min at RT in order to stabilize 
luminescent signal and luminescence was recorded using the Glomax multiplate 
reader. 
 
2.6 BrdU Proliferation Assay 
The assay is based on the detection of BrdU incorporated into genomic DNA of 
proliferating cells. Cells grown in 96-well tissue-culture micro titter plates are labelled 
with BrdU. During this labelling period, BrdU is incorporated in place of thymidine 
into the DNA of cycling cells.  
The stock of 1:100 aliquots were prepared and stored at -20ºC. For Anti-Pod and 
washing solution, the working solution of 1:100 (stock+ dilution solution) was 
prepared. 5x10
3 
bEnd5 cells were seeded in 100μl supplemented DMEM culture 
medium per well in black walled 96-well microtiter plates, (Biocam/Biotech S.A.) and 
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incubated for 24hrs. Media was then removed and cells were incubated with 
concentrations of 0.00001mM, 0.0001mM, 0.01mM, 0.1mM and 1mM of pure MA 
and street MA samples for 24, 48, 72 and 96hrs. Wells containing medium without 
cells were prepared in order to obtain a value for background luminescence, while 
control wells contained cells grown in supplemented media only. Post incubation 
times, 10µl of BrdU was added to all wells and the microtiter plate was re-incubated 
for 2hrs at 37ºC. Thereafter, the labelling medium was removed and 200µl FixDenat 
was added and fixation was allowed at RT for 30min. The FixDenat was removed 
after fixation and 100µl anti-BrdU-POD was added to each well and incubated for 
90min at RT. After removal of the anti-Brdu-POD, the microtiter plate was washed 
with washing buffer three times (200µl). Subsequently 100µl of substrate was added 
to all well contents and gently shaken for 10min on an orbital shaker. The plate was 
read using luminescence Glomax multiplate reader.  
 
2.7 Flow Cytometry 
FACS (fluorescence activated cell sorter), is a type of flow cytometry that analyses 
internal structures of cells and separates them into different groups. In this application 
a cell suspension is forced  through a tube  in the form of droplets containing single 
cells.  
Trypsinated cells were suspended in ice-cold 70% Ethanol (EtOH) to a final volume 
of 10ml and were placed at 20ºC for a minimum of 2hrs. Cells were centrifuged at 
1000 rpm for 5min at room temperature (RT), the EtOH carefully removed and the 
loose pellet resuspended in 1ml ice-cold 70% EtOH. The resuspended pellet was 
transferred to an eppendorf and centrifuged at 1000 rpm with a bench top microfuge 
 
 
 
 
39 
 
for 1min to ensure pellet formation. The remaining EtOH was removed and the pellet 
was resuspended in 1ml (PBS) (White Sci. S.A.). RNase (20mg/ml) diluted in 
phosphate buffered saline PBS at a ratio 1:199 respectively was prepared and the 
required volume (50µl per 10
4
 cells) added and incubated at RT for 1½hrs. The 
propidium iodide (PI) staining solution was prepared using 0.1% Triton-X100 (Cas 
No: 9002-93-1), 0.003M MgCl2, 0.1M NaCl, 0.1Ml piperazine-N,N′-bis(2-
ethanesulfonic acid) (PIPES) buffer (Sigma S.A.) pH6.8, 1mg/ml PI with the final 
volume made up with distilled water. Approximately 20min preceding flow cytometry 
analysis the required volume of PI staining solution was added to the cells (9X 
volume of RNase/PBS solution).  
 
2.7.1 Cell Cycle Analysis  
bEnd5 (5x10
5)
 cells were seeded in supplemented DMEM in 25ml flasks. Individual 
samples were analysed using the Becton Dickinson FACSCalibur flowcytometer with 
a 488nm coherent laser. Each analysis was based on at least 10 000 events.  The 
software used for acquisition of data, was Cellquest Pro version 5.2.1. The cell 
population was identified and gated (R1) on a forward scatter (FSC) vs. side scatter 
(SSC) dot plot in acquisition mode. Fluorescent Channel 2(FL2) at 575nm was used 
for propidium iodide detection. A dot plot of FL2A(area) vs FL2W(width) was used 
to identify single cells (R2) and thus eliminate doublets. A histogram plot of FL2A 
was used to enumerate G1/G0, S-phase and G2/M populations. The combined 
parameters of FSC, SSC, FL2A and FL2W displayed the results. A threshold of 52 on 
the FSC channel was set to remove sample debris. Nile Red fluorescent particles were 
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used for instrument standardization, stability and reproducibility. Analysis of the 
results were performed using Modfit version 2.0 software. 
 
2.8 Statistical Analysis 
Medcalc (version 11.5.1), using the Wilcoxon Rank Sum Test for not normally 
distributed, unpaired samples was employed for statistical analysis. All outliers were 
statistically identified by Box-and Whisker plot and removed before determining 
significance between the means, in which P<0.05 was designated as significantly 
different. 
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CHAPTER 3 
3.1 Chemical analysis of street MA samples using GC-MS. 
 
All samples were qualitatively analyzed for MA presence by gas-chromatography 
mass spectrometry (GC-MS). All data (Fig. 3.1-3.4) represent the presence of the 
MA. The presence of the MA was detected at elevation time of ranging between 8.5 
to 8.9min.  
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Figure 3.1. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.69min. B) total ion chromatogram of methamphetamine analysed  using MS for street MA sample 1 
showing the chemical signature of MA.  
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Figure 3.2. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.34min. B) total ion chromatogram of methamphetamine analysed  using MS for street MA sample 2 
showing the chemical signature of MA. 
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Figure 3.3. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.64min. B) total ion chromatogram of methamphetamine analysed  using MS for street MA sample 3 
showing the chemical signature of MA.  
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Figure 3.4. The above figure illustrates: A) methamphetamine analysed using GC elucidated at 
8.34min. B) total ion chromatogram of methamphetamine analysed  using MS for street MA sample 4 
showing the chemical signature of MA.  
 
3.2 The effect of pure and street MA on the viability of bEnd5 cells  
Table 3.1 and figure 3.5 shows that no dead cells were observe at 24hrs except in the 
higher concentration (1mM). However, few dead cells were seen at 48, 72 and 96hrs 
of the experiment. Statistically, no significant difference (P>0.05) was observed in % 
cell viability between control and bEnd5 cells exposed to pure MA at all time 
intervals. 
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Table 3.1: The effect of selected concentrations of pure MA on % viability of bEnd5 cells at various 
time intervals (Mean ± SEM, n=6) 
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Figure 3.5. Effect of pure MA (mM) on viability of bEnd5 cells at selected concentrations between 24  
and 96hrs. Results were displayed as mean ± SEM, (n=6).  
 
Table 3.2 and figure 3.6 illustrate that during 24hrs of exposure of bEnd5 cells no 
dead cells were observed, while a few dead cells were observed at 48, 72 and 96hrs of 
the experiment. There was no statistical difference (P>0.05) between control values in 
% cell viability observed when bEnd5 cells were exposed to street MA sample 1.  
Compound 
Time 
Pure MA  
24 hr 48 hr 72 hr 96 hr 
Control  93.89±4.52 98.97±2.83 99.78±0.14 98.99±0.87 
0.0001mM 100.00±0.00 97.92±0.61 99.51±0.13 96.10±0.69 
0.001mM 100.00±0.00 98.97±0.40 99.78±0.11 98.97±0.24 
0.01mM 100.00±0.00 99.50±0.23 94.78±1.41 99.58±0.16 
0.1mM 100.00±0.00 97.49±0.69 99.70±0.15 96.54±0.97 
1mM 97.62±2.38 94.67±1.71 99.42±0.29 99.43±0.22 
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Table 3.2: The effect of selected concentrations of street MA sample 1 on % viability of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 1 
24 hr 48 hr 72 hr 96 hr 
Control  92.67±4.52 96.31±23.83 97.58±00.18 92.13±1.47 
0.0001mM 100.00±0.00 97.83±0.74 99.50±0.17 96.10±0.69 
0.001mM 100.00±0.00 98.77±0.42 99.86±0.14 98.95±0.29 
0.01mM 100.00±0.00 99.40±0.26 99.47±0.22 94.78±1.41 
0.1mM 100.00±0.00 97.05±0.65 99.64±0.17 88.03±5.08 
1mM 96.43±3.57 94.67±1.71 99.42±0.29 99.35±0.34 
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Figure 3.6. Effect of street MA 1 (mM) on viability of bEnd5 cells at selected concentrations between 
24  and 96hrs. Results were displayed as mean ± SEM, (n=6).  
 
Table 3.3 and figure 3.7 results indicate no significant difference in % cell viability 
(P>0.05) between control bEnd5 cells and those exposed to street MA sample 2 at all 
time intervals.  
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Table 3.3: The effect of selected concentrations of street MA sample 2 on % viability of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 2 
24 hr 48 hr 72 hr 96 hr 
Control  97.11±0.51 96.31±1.01 98.91±0.17 95.47±1.28 
0.0001mM 97.67±0.31 95.92±0.79 98.90±0.08 97.52±0.26 
0.001mM 98.09±0.31 97.47±0.34 98.82±0.06 96.79±0.44 
0.01mM 97.05±0.34 98.02±0.33 98.93±0.21 97.29±0.28 
0.1mM 97.08±0.33 97.65±0.28 98.88±0.20 95.80±0.36 
1mM 96.75±0.31 96.13±0.32 98.08±0.26 95.84±0.64 
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Figure 3.7. Effect of street MA 2 (mM) on viability of bEnd5 cells at selected concentrations between 
24  and 96hrs. Results were displayed as mean ± SEM, (n=6).  
 
Table 3.4 and figure 3.8 exhibits bEnd5 cell were exposed street MA sample 3, results 
showed that there were similar number of viable cells compared to that of controls 
however, no statistically significant difference between control and (P>0.05) in % cell 
viability in all time intervals was observed.  
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Table 3.4: The effect of selected concentrations of street MA sample 3 on % viability of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 3 
24 hr 48 hr 72 hr 96 hr 
Control  94.49±2.97 97.40±0.21 98.29±0.15 99.34±0.07 
0.0001mM 79.42±1.47 97.91±0.15 98.00±0.22 99.24±0.10 
0.001mM 88.88±0.85 97.64±0.24 95.95±2.06 98.47±0.14 
0.01mM 89.92±0.82 97.40±0.14 97.95±0.21 97.95±0.21 
0.1mM 73.75±1.79 95.39±0.92 96.16±0.70 98.96±0.09 
1mM 81.40±2.46 95.61±0.51 96.64±0.39 98.43±0.18 
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Figure 3.8. Effect of street MA 3 (mM) on viability of bEnd5 cells at selected concentrations between 
24  and 96hrs. Results were displayed as mean ± SEM, (n=6).  
 
Table 3.5 and figure 3.9 illustrates that cells exposed to street MA sample 4 indicated 
a similar % viability of cells compared to control data. At the concentrations used, 
data displayed no statistically significant differences between % cell viability and the 
control at all time intervals (P>0.05). 
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Table 3.5: The effect of selected concentrations of street MA sample 4 on % viability of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
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Figure 3.9. Effect of street MA 4 (mM) on viability of bEnd5 cells at selected concentrations between 
24  and 96hrs. Results were displayed as mean ± SEM, (n=6). 
  
 
 
 
 
Compound 
Time 
Street MA sample 4 
24 hr 48 hr 72 hr 96 hr 
Control  94.49±1.21 98.65±0.26 98.26±0.27 96.32±1.94 
0.0001mM 92.75±0.82 99.11±0.10 99.53±0.10 99.30±0.12 
0.001mM 93.75±0.75 98.94±0.05 99.20±0.16 99.26±0.13 
0.01mM 92.48±0.45 99.03±0.09 99.27±0.21 98.90±0.28 
0.1mM 90.62±0.71 98.94±0.21 98.90±0.22 99.00±0.12 
1mM 93.59±2.20 98.84±0.37 97.76±0.70 98.50±0.16 
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3.3 The effect of selected concentrations of pure and street MA on the % cell 
growth of bEnd5 cells at various time intervals  
 
The data for % cell growth was normalized against control groups, thus the control  
data is reflected at 100% in figures and tables (see materials and methods in chapter 
2), and experimental data was expressed as percentage.  
 
3.3.1 Effect of pure MA (Table 3.6 and Figure 3.10) 
At the lower concentrations (0.0001-0.001mM) pure MA caused a decreased in % cell 
growth over the period of 24-96hrs (P=0.0105) by 4.35-fold relative to control. This 
decrease in trend was observed at 24 and 48hrs (P=0.0864). Relative to control, the 
lower concentrations showed to be suppressed by MA in cell growth. However, the % 
cell growth was not significantly different to the control (P≥0.05) at 72hrs.  
 
The highest concentrations (0.01-1mM) initially displayed stimulation at 24 and 
48hrs. This increase was significant (P=0.0433) for 0.1mM at 48hrs and 72hrs 
whereas at 96hrs pure MA caused a significant decrease (P=0.0275). This trend of 
decreased % cell growth was observed at 72 and 96hrs (P=0.0285) at 0.1mM.  
Exposure at 24hrs: At 24hrs the effects of MA can be divided into two groups: lower 
concentrations and higher concentrations. The lower concentrations (0.0001-0.01mM) 
resulted in the significant stimulation (P˂0.05) of cell growth compared to the control, 
where the higher concentrations showed a suppression in cell growth % which was 
statistically significant at P˂0.05. A significant decrease in cell growth % was 
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observed (P= 0.0275) at 0.0001mM and 0.1mM and a 2.70-fold (P= 0.0209) decrease 
in % growth was observed at 0.0001mM and 1mM.  
Exposure at 48hrs: % Cell growth  exhibited a biphasic dose response type profile at 
48hrs, then plateaued for all the concentrations used, except 1mM which showed non-
significant  suppression of cell growth %.  
Exposure at 72hrs: At 72hrs, % cell growth showed to be approaching that of the 
control with the higher concentration (1mM) showing less % cell growth than that of 
controls. However, a statistically significant decrease (P=0.0143) was observed 
between the higher concentrations 0.01mM and 1mM.  
Exposure at 96hrs: All bEnd5 cells exposed to pure MA illustrated % growth that 
was suppressed below that of controls. This suppression was found to be statistically  
significant (P˂0.05) for all the concentrations 
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Table 3.6:  The effect of selected concentrations of MA on the % cell growth of bEnd5 cells at the 
indicated time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Pure MA 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 319.74±66.796 163.43±31.26 122.88±28.06 73.48±6.63 
0.001mM 305.26±46.78 211.55±22.60 158.00±34.52 57.04±3.86 
0.01mM 192.63±39.12 257.76±27.73 172.27±18.38 76.795±3.39 
0.1mM 98.69±14.95 253.32±52.28 130.24±17.66 89.63±4.79 
1mM 118.43±10.19 190.98±27.40 89.26±6.92 65.45±6.69 
 
 
 
Figure 3.10. The above figure illustrate % cell growth when beEnd5 cell are exposed to pure MA at 
different time intervals. * indicates a significant difference P˂ 0.05 relative controls values. Results 
were displayed as mean ± SEM, (n=6). 
 
 * 
 
* 
 
* 
 
* 
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3.3.2 Effect of street  MA sample 1 (Table 3.7 and Figure 3.11) 
The profiling in % cell growth for the selected street MA concentration mimicked the 
profiling of pure MA over the time between 24 and 96hrs (compare figure 3.6 and 
3.7). For the lower concentrations (0.0001mM-0.001mM) % cell growth decreased by 
5.18-fold at 96hrs (see fig. 3.7) relative to the control.  Over the period 24 to 72hrs, all 
concentrations of street MA sample 1 exhibited enhanced cell growth. This enhanced 
cell growth was most noticeable in the lower concentrations (0.0001-0.001mM) at 
24hrs. At the higher concentrations (0.1-1mM), enhanced cell growth was not as 
pronounced.  
Between 48 and 72hrs, the enhanced cell growth was not as prolific as it was at 24hrs 
but was significant compared to the control (P≤0.0275). The exception to this trend 
was at a concentration of 1mM at 72hrs, which showed significant suppression of cell 
growth relative to control (P˂0.05).  
At 96hrs, all concentrations, relative to the control, were significantly suppressed 
(P≤0.02). 
Exposure at 24hrs: bEnd5 cells exposed to lower concentrations (0.0001-0.01mM)  
of street MA sample 1 exhibited stimulation in % cell growth, while, the two higher 
concentrations (0.1-1mM) showed suppression.  
Exposure at 48hrs: Results displayed a biphasic effect in cell growth %: for the 
lower concentrations (0.0001-0.01mM), a dose response profile was observed, 
whereas for the higher concentrations (0.1-1mM), the dose profile in cell growth %  
was reversed compare to that of the control.   
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Exposure at 72hrs: At 72hrs, % cell growth   was greater than the control except in 
the highest concentration (1mM).  
Exposure at 96hrs: Results showed that cell growth % was significantly lower than 
that of controls, indicating MA sample suppression in cell growth.  
 
Table: 3.7:  The effect of selected concentrations of street MA sample 1 on the % cell growth of bEnd5 
cells at the indicated time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 1 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 391.66±98.67 106.08±14.18 122.88±28.06 75.66±6.83 
0.001mM 412.50±88.09 183.43±19.60 158.00±34.52 62.27±2.22 
0.01mM 362.50±76.58 223.50±24.05 172.27±18.38 79.07±3.49 
0.1mM 140.00± 24.49 192.73± 44.25 130.24± 17.66 86.29± 4.97 
1mM 150.00± 27.00 150.82± 24.39 82.153± 9.08 66.26± 3.26 
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Figure 3.11. The above figure illustrate % cell growth when bEnd5 cell are exposed to Street MA 1 at 
different time intervals. * indicates a significant difference  P˂ 0.05 to that of the controls. Results were 
displayed as mean ± SEM, (n=6). 
 
 
3.3.3 Effect of street  MA sample 2 ( Table 3.8 and Figure 3.12)  
At the lower concentrations (0.0001-0.001mM) street MA sample 2 induced a 
significant increase in % cell growth  at 24 and 48hrs (P=0.0275). 
At the higher concentrations (0.01-1mM), street MA sample 2 resulted in a significant 
suppression (P≤0.009) of % cell growth at 48 and 72hrs in.  
Exposure at 24hrs: Results exhibited a dose response profile, with the higher 
concentrations (0.1-1mM) illustrating a significant decrease (P˂0.05) compared to the 
control.  
Exposure at 48hrs: Cell growth % exhibited significant stimulation (P˂0.05) by MA 
compared to control. This increase was also observed when 0.01mM was compared 
with 0.1mM and 1mM during the sampling time of the experiment.   
* 
* * 
* 
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Exposure at 72hrs: The lower concentrations (0.0001-0.001mM) displayed a  greater 
value in cell growth %, while the intermediate concentrations (0.01-0.1mM) showed 
results which are similar to each other. The highest concentration (1mM) displayed  
significant suppression (P˂0.02) compared to control with P˂0.05.  
Exposure at 96hrs: The two higher concentrations (0.1-1mM) showed cell growth % 
that is lower than that of the lower concentrations (0.0001-0.01mM), with 1mM 
displaying cell growth that is less than that of the controls, indicating suppression 
(P˂0.05).  
 
Table: 3.8  The effect of selected concentrations of street MA sample 2 on the % cell growth of bEnd5 
cells at the indicated time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 2 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 172.45±18.63 164.71±18.13 155.23±7.38 184.29±26.46 
0.001mM 159.39±25.04 258.40±11.397 156.91±16.57 154.76±21.11 
0.01mM 112.74±6.34 213.37±10.22 96.83±9.80 187.22±27.999 
0.1mM 88.61±12.22 116.198±8.07 103.03±7.05 104.10±5.42 
1mM 69.29±5.23 136.52±11.21 82.24±3.99 85.09±4.63 
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Figure 3.12. The above figure illustrate % cell growth when bEnd5 cell are exposed to Street MA 2 at 
different time intervals. * indicates a significant difference P˂ 0.05 to that of the controls. Results were 
displayed as mean ± SEM, (n=6). 
 
3.3.4 Effect of street  MA sample 3 (Table 3.9 and Figure 3.13) 
Over the period of 24 to 96hrs, all the concentrations of street MA sample 3 induced 
MA suppression in % cell growth, with the exception of  the lower concentration 
(0.001 and 0.01) which displayed similar results to the control.  
Exposure at 24hrs: At 24hrs, cell growth % was suppressed at all the concentrations 
used, the exceptions were the intermediate concentrations (0.001-0.01mM) which 
illustrated similar results to that of the control.  
Exposure at 48hrs: Cell growth % was suppressed at all the selected concentrations. 
Exposure at 72hrs: At 72hrs, cell growth % was suppressed at all the selected 
concentrations with higher concentration (1mM) showing the most suppressed % cell 
growth.   
Exposure at 96hrs: Cell growth % was suppressed through all of the selected 
concentrations, and was significantly lower than that of the control (P˂0.05).  
* 
* 
* * 
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Table:3.9 The effect of selected concentrations of street MA sample 3 on the % cell growth of bEnd5 
cells at the indicated time intervals (Mean ± SEM, n=6)  
Compound 
Time 
Street MA sample 3 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 47.66±3.71 88.86±4.10 77.29±6.08 89.21±6.09 
0.001mM 98.81±5.57 53.45±9.58 76.06±2.14 53.595±5.84 
0.01mM 107.23±9.95 56.26±4.63 65.71±7.01 61.57±3.27 
0.1mM 25.76±2.02 43.25±3.896 96.16±0.698 66.43±8.13 
1mM 50.11±6.88 34.37±3.46 26.41±1.58 47.998±3.43 
 
 
Figure 3.13. The above figure illustrate % cell growth when cell are exposed to Street MA 3 at 
different time intervals. * P˂ 0.05 indicate a significant difference from that of the controls. Results 
were displayed as mean ± SEM, (n=6). 
 
3.3.5 Effect of street  MA sample 4 (Table 3.10 and Figure 3.14) 
At the lower concentrations (0.0001-0.001mM), it was observed that MA-induced 
stimulation of % cell growth for the time period 24, 48, 72 and 96hrs.  
* 
* * * 
* 
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At higher concentrations (0.1-1mM), two trends were observed: at 0.1mM 
suppression (P=0.0090) of MA-induced cell growth % occurred between period of 24 
to 72hrs. At 1mM, MA-induced stimulation of % cell growth occurred (P=0.0105) 
between 24 and 96hrs. This increase trend was extended to 48 and 72hrs.  
Exposure at 24hrs: Results displayed suppression in % cell growth as the 
concentration of drug increased with the intermediate (0.001-0.01mM) concentrations 
showing similar results.  
Exposure at 48hrs: All the concentrations used showed similar results indicating 
stimulation in cell growth %, with the exception of the highest concentration (1mM) 
displaying greater suppression.  
Exposure at 72hrs: The highest concentration (1mM) showed suppression in % cell 
growth, whereas, the other concentrations displayed stimulation as compared to 
controls (P˂0.05).  
Exposure at 96hrs: Results demonstrated that the bEnd5 cells exposed to different 
concentrations shows similar stimulatory % cell growth with, 1mM being the only 
one showing results that are similar to that of the controls. Throughout the experiment 
at 96hrs, 1mM MA exposure showed a significant increase in % cell growth when 
compared to other selected concentrations (P≤0.0209).  
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Table:3.10 The effect of selected concentrations of street MA sample 4 on the % cell growth of bEnd5 
cells at the indicated time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 4 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 156.04±12.87 150.05±9.53 156.098±13.94 161.597±6.39 
0.001mM 130.04±16.16 151.93±8.93 142.74±11.28 141.59±4.83 
0.01mM 131.06±6.18 122.35±16.62 160.16±13.35 146.33±8.23 
0.1mM 82.32±3.07 129.296±10.70 107.43±8.05 136.17±12.55 
1mM 47.45±9.08 29.37±3.20 34.71±1.92 98.93±6.48 
 
 
 
Figure 3.14 . The above figure illustrate % cell growth when bEnd5 cell are exposed to Street MA 4 at 
different time intervals. * indicates a significant difference P˂ 0.05 to that of the controls. Results were 
displayed as mean ± SEM, (n=6). 
 
* * * * 
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3.4 The effect of selected concentrations of pure and street MA on the % ATP 
production in bEnd5 cells at various time intervals 
This ATP assay was used  to determine the relative concentration of ATP in control 
compared to MA exposed cells. The assay determined cell viability via the detection 
of ATP activity which is indicative of the presence of metabolically active cells.  
 
3.4.1 Effect of pure MA on ATP production (Table 3.11 and Figure 3.15) 
At the lower concentrations (0.0001-0.001mM), pure MA caused dose-related 
increase in ATP production over time at 24 and 96hrs (P˂0.05). Compared to the 
control, 0.001mM displayed a significant increase (P≤0.0209) while, 0.0001mM 
showed results similar to that of the control (P≥0.05). In of all the concentrations 
used, ATP production increased at 48hrs and decreased at 72hrs (P≤0.0209), 
thereafter, followed by an  increase at 96hrs (P˂0.05) relative to controls (Table 3.11 
and Figure 3.11).  
Exposure at 24hrs: ATP produced by bEnd5 cells was slightly elevated yet 
statistically significant to that of controls, except at the lowest concentration 
(0.0001mM). bEnd5 treated with 0.0001mM displayed significant difference 
(P≤0.002) of ATP production to all the concentrations of MA.  
Exposure at 48hrs: ATP levels increased with an increase in MA concentration, with 
0.001mM and 0.01mM showed similar response. Exposure of bEnd5 to 0.1mM MA 
showed a significant increase in ATP levels (P=0.009) relative to cells exposed to 
0.0001mM, and  0.001mM.  
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Exposure at 72hrs: A dose related decrease in ATP production occurred at 72hrs 
where the lower concentrations of MA produced more ATP. All these concentration 
were significantly less than control values (P˂0.05).   
Exposure at 96hrs: With the exception of 0.0001mM, all doses of MA exhibited 
significantly greater ATP production relative to the control.  
Table 3.11: The effect of selected concentrations of pure MA on % ATP of bEnd5 cells at various time 
intervals (Mean ± SEM, n=6) 
Compound 
Time 
Pure MA 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 89.36±2.38 108.45±5.50 86.55±5.25 93.30±6.77 
0.001mM 108.80±2.76 123.69±3.10 79.69±1.39 155.97±18.74 
0.01mM 111.25±3.68 123.03±2.50 71.72±1.02 161.39±18.54 
0.1mM 104.59±3.60 157.11±3.85 69.68±1.47 152.51±19.61 
1mM 101.89±2.77 174.40±3.68 66.07±2.44 132.31±9.97 
 
 
Figure 3.15. Effect on % ATP of cells exposed to pure MA. * indicates a significant difference P˂ 0.05 
relative controls values. Results were displayed as mean ± SEM, (n=6). 
* 
* * 
* 
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3.4.2 Effect of street MA sample 1 on ATP production (Table 3.12 and Figure 
3.16) 
For all the selected concentrations used, street MA sample 1 caused an increase 
between 24 and 96hrs (P=0.0275). All concentrations displayed a significant increase 
(P≤0.0275) between 24 and 96hrs. Street MA sample 1 results displayed suppression 
in ATP production at 48hrs relative to control values which continued up till 72hrs 
(P˂0.05) (table 3.12 and figure 3.12). 
Exposure at 24hrs: With the exception of 0.0001mM, ATP production was 
significantly higher than that of control (P≤0.009).  
Exposure at 48hrs: ATP production was significantly suppressed (P˂0.05) by MA at 
all selected concentrations, with the exception of the intermediate concentration 
(0.01mM).  
Exposure at 72hrs: This trend in decrease (P≤0.02) of ATP production relative to 
control continued at 72hrs. The higher concentration (1mM) showed a more acute 
suppression compare to other concentrations. 
Exposure at 96hrs: The suppression of ATP production was reversed at all 
concentrations, with all bEnd5 cells exposed to MA sample 1 showing elevation of 
ATP production relative to control values. 
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Table 3.12: The effect of selected concentrations of street MA sample 1 on % ATP of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
 
Compound 
Time 
Street MA sample 1 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 83.37±3.23 76.63±2.08 68.80±1.97 156.49±14.68 
0.001mM 113.04±4.07 91.35±0.72 69.84±2.59 162.10±18.74 
0.01mM 116.87±3.63 106.18±5.85 85.14±2.32 159.15±14.66 
0.1mM 113.12±3.18 78.29±1.46 81.35±5.34 150.36±12.00 
1mM 101.72±1.81 84.51±0.68 48.98±0.68 122.41±5.82 
 
 
 
 
 
Figure 3.16. Effect on % ATP of cells exposed to street MA 1. * indicates a significant difference P˂ 
0.05 relative controls values. Results were displayed as mean ± SEM, (n=6). 
 
* * 
* 
* 
* 
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3.4.3 Effect of street MA sample 2 on ATP production (Table 3.13 and Figure 
3.17) 
Exposure of bEnd5 cells to both the lower and the higher concentrations results 
showed a significant increase between 24 and 96hrs (P≤0.05) with the exception of 
0.01mM concentration. At 72hrs, all the concentrations used displayed a significant 
decrease (P≤0.0209) in ATP production compared to the control (Table 3.13 and 
Figure 3.13). This suppression was reversed at 96hrs with all cells exposed to MA 
displaying significant elevation of ATP production with the exception of 0.01mM. 
Exposure at 24hrs: The higher concentrations (0.1-1mM) were significantly different 
to controls, with 0.01 and 0.1mM MA exposed cells elevating ATP production, while, 
1mM MA suppressed ATP production (P˂0.05). 
Exposure at 48hrs: bEnd5 cells produced ATP that was not statistically different to 
that of the control (P≥0.05).  
Exposure at 72hrs: ATP production was decreased when bEnd5 cells were exposed 
to the selected concentrations of MA.   
Exposure at 96hrs: All selected concentrations of MA exhibited a significant 
increase in ATP production relative to that of the control (P˂0.05), with the exception 
of 0.01mM MA exposed cells, which did not statistically differ from the control. 
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Table 3.13: The effect of selected concentrations of street MA sample 2 on % ATP of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 2 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 94.39±4.47 91.13±5.76 85.11±4.73 124.12±9.14 
0.001mM 100.25±2.73 101.24±1.29 86.02±2.59 141.83±12.49 
0.01mM 109.60±3.36 99.63±3.93 87.30±1.47 98.11±7.88 
0.1mM 111.75±3.18 107.01±4.12 75.72±5.34 145.34±10.63 
1mM 75.12±1.418 96.08±3.17 75.14±2.32 134.43±3.03 
 
 
Figure 3.17. Effect on % ATP of cells are exposed to street MA sample 2. * indicates a significant 
difference P˂ 0.05 relative to controls values. Results were displayed as mean ± SEM, (n=6). 
 
3.4.4 Effect of street MA sample 3 on ATP production (Table 3.14 and Figure 
3.18) 
A similar trend was observed when pure MA was exposed to bEnd5 cells: similar 
values to that of the control in ATP production was observed at 24hrs, slight elevation 
at 48hrs, acute suppression across all the concentrations at 72hrs, and at 96hrs 
* 
* 
* * 
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significant increased production of ATP. Specific variation will be described at the 
specific selected time frames.  
Exposure at 24hrs: With the exception of 0.1mM, doses of MA exhibited similar 
results compared to the control (P≥0.05).   
Exposure at 48hrs: ATP levels increased between (0.001-0.1mM) compared to the 
control. 0.0001mM and 1mM showed similar results to that of the control.  
Exposure at 72hrs: All the selected concentrations of MA exhibited suppression in 
ATP production.  
Exposure at 96hrs: ATP levels produced by bEnd5 cells exhibited a significant 
increase (P≤0.0433) to all other concentrations of MA with the exception of 1mM, 
which showed similar results to the control.  
 
Table 3.14.The effect of selected concentrations of street MA sample 3 on % ATP of bEnd5 cells at 
various time intervals (Mean ± SEM), n=6 
Compound 
Time 
Street MA sample 3 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 101.48±1.80 101.48±4.20 79.39±2.85 123.56±5.88 
0.001mM 101.24±2.13 128.67±6.23 87.44±0.35 114.34±11.73 
0.01mM 101.57±1.57 131.09±3.98 85.46±5.22 120.93±8.73 
0.1mM 111.60±1.27 123.13±3.51 82.34±2.16 111.34±6.75 
1mM 104.37±2.11 92.62±3.60 97.04±2.84 93.51±7.98 
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Figure 3.18. Effect on % ATP of cells are exposed to street MA sample 3. * indicates a significant 
difference P˂ 0.05 relative controls values. Results were displayed as mean ± SEM, (n=6). 
  
3.4.5 Effect of street MA sample 4 on ATP production (Table 3.15 and Figure 
3.19) 
MA street MA samples differed most to that of the pure MA pattern. Lower 
concentrations (0.0001-0.001mM) showed a significant increase (P=0.0143) between 
24 and 96hrs. The higher concentrations (0.1-1mM) showed no significant difference 
compared to the control (P≥0.05). A significant decrease (P˂0.05) was observed at 48 
and 72hrs for 0.0001mM and 1mM.   
Exposure at 24hrs: bEnd5 cells treated with selected concentrations of MA displayed 
a significant increase (P≤0.0090) compare to the control with the exception of the 
lower concentration (0.0001mM).  
Exposure at 48hrs: Intermediate concentrations (0.001-0.1mM) showed an increase 
in ATP production. Suppression of ATP production occurred at 1mM MA.  
* 
* * 
* 
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Exposure at 72hrs: The lower concentrations displayed less ATP production than the 
control (P˂0.0143). 
Exposure at 96hrs: The lower concentrations (0.0001-0.001mM) showed a 
suppression in ATP production, while the higher concentrations (0.1-1mM) showed 
results that were slightly (P˂0.05) greater than that of the control.  
 
Table 3.15: The effect of selected concentrations of street MA sample 4 on % ATP of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA sample 4 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 95.54±3.03 95.07±1.35 79.02±3.38 78.26±1.41 
0.001mM 116.45±2.23 124.73±0.68 90.99±7.02 72.77±7.05 
0.01mM 117.47±3.31 118.26±1.35 100.92±1.29 106.97±21.82 
0.1mM 117.96±4.75 116.45±1.44 106.17±1.18 102.51±9.09 
1mM 105.02±2.41 90.41±1.07 95.55±1.96 103.53±7.87 
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Figure 3.19. Effect on % ATP of cells are exposed to street MA sample 4. * indicates a significant 
difference P˂ 0.05 relative controls numbers. Results were displayed as mean ± SEM, (n=6). 
  
3.5 The effect of selected concentrations of pure and street MA samples on 
DNA proliferation of bEnd5 cells at various time intervals 
 
Cells assessed with the labeling medium containing BrdU. The BrdU is incorporated 
in place of thymidine during replication thus indicative of newly synthesized DNA of 
a proliferating cell.  
3.5.1  Effect of pure MA on DNA proliferation (Table 3.16 and Figure 3.20) 
The two lower concentrations (0.0001-0.001mM) MA caused a significant decrease in 
% DNA synthesis at 24 and 96hrs compared to controls (P≤0.05); this decrease trend 
continued at 48 and 72hrs. The higher concentrations (0.1-1mM) of MA induced 
suppression at 24 and 96hrs, while a significant decrease was observed when bEnd5 
cells  were exposed to 1mM (P=0.0275).  
* * * 
* 
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Exposure at 24hrs: The lower concentrations (0.0001-0.001mM) induced stimulation 
in DNA synthesis compared to the control, while the higher concentration displayed 
suppression of DNA. 
Exposure at 48hrs: DNA synthesis levels differed at all the concentrations used: 
0.001mM and 1mM MA stimulated DNA synthesis, while 0.0001mM and 0.1mM 
showed suppression of DNA synthesis compared to the control (P˂0.05).    
Exposure at 72hrs: DNA synthesis levels produced by bEnd5 cells was similar to 
that of the control at 72hrs (P≥0.05).  
Exposure at 96hrs:  All concentrations of selected pure MA exhibited significant 
decrease of DNA synthesis relative to the control.  
 
Table 3.16: The effect of selected concentrations of pure MA on DNA synthesis of bEnd5 cells at 
various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Pure MA 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 143.64±8.32 92.12±1.18 97.90±4.90 66.39±6.15 
0.001mM 138.13±13.74 146.24±12.04 99.07±6.53 91.21±9.77 
0.01mM 58.27±4 102.03±8.97 90.31±7.38 56.83±11.58 
0.1mM 94.94±14.20 62.02±4.20 101.73±10.53 87.38±9.39 
1mM 86.31±13.42 117.87±5.07 101.73±10.53 72.11±10.49 
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Figure 3.20. Effect of pure MA on % DNA synthesis. * P˂ 0.05 indicate a significant difference from 
that of the controls. Results were displayed as mean ± SEM. 
 
3.5.2 Effect of street sample 1 MA on DNA proliferation (Table 3.17 and Figure 
3.21) 
No clear pattern was observed over the period 24 to 96hrs.  
Exposure at 24hrs: Both the lower and the higher concentrations exhibited 
significant decrease in DNA synthesis relevant to the control (P≤0.0339). 
Exposure at 48hrs: A decrease in DNA synthesis occurred at 48hrs with the 
exception of 0.001mM which was elevated significantly (P˂0.0209) compared to the 
controls.  
Exposure at 72hrs: At 72hrs, bEnd5 cells produced DNA replication that was less 
than that of the controls at the lower concentrations (0.0001-0.001mM), while the 
higher concentrations (0.1-1mM) showed elevation of DNA synthesis (P˂0.05).   
* 
 
* 
 
* 
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Exposure at 96hrs:  0.0001mM displayed supersession (P=0.0433), while 0.001mM 
showed elevated results to that of the control. The higher concentrations (0.1-1mM) 
displayed results that are similar to that of the control (P≥0.05). 
 
Table 3.17: The effect of selected concentrations of street MA sample 1 on DNA synthesis of bEnd5 
cells at various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA 1 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 85.43±2.97 54.12±4.52 17.82±4.74 79.85±5.06 
0.001mM 95.59±3.65 127.30±3.99 49.99±2.15 105.50±6.87 
0.01mM 67.70±8.38 104.98±3.89 194.79±51.94 93.75±12.73 
0.1mM 86.35±6.51 84.00±19.62 112.86±16.98 106.20±20.30 
1mM 71.68±16.23 55.20±12.71 105.47±6.23 93.50±14.15 
 
 
 
Figure 3.21. Effect of street MA sample 1 on % DNA synthesis. * P˂ 0.05 indicate a significant 
difference from that of the controls. Results were displayed as mean ± SEM. 
* 
 
* 
 * 
 
* 
 
* 
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3.5.3 Effect of street sample 2 MA on DNA proliferation (Table 3.18 and Figure 
3.22) 
No clear pattern was observed over the period 24 to 96hrs.  
Exposure at 24hrs: All the concentrations produced elevated DNA synthesis with the 
exception of 0.001mM, which showed suppression of DNA synthesis (P=0.0339).  
Exposure at 48hrs: Similar DNA synthesis was observed at 48hrs in all 
concentrations of selected MA except 1mM.  
  
Exposure at 72hrs:  At 72hrs, a biphasic response was observed which caused a 
dose-related elevation to MA samples at (0.0001-0.01mM), however, a dose related 
decrease was observed at (0.1-1mM).   
 
Exposure at 96hrs: All the concentrations of MA showed significant increase in 
DNA synthesis relative to the control, with the exception of 0.0001mM.  
 
Table 3.18:The effect of selected concentrations of street MA sample 2 on DNA synthesis of bEnd5 
cells at various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA 2 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 58.63±8.85 101.93±2.16 94.50±27.23 70.81±10.60 
0.001mM 115.22±7.22 119.01±9.38 150.27±10.77 130.09±8.54 
0.01mM 110.98±11.11 114.58±1.33 194.79±51.94 93.75±12.73 
0.1mM 125.00±3.09 104.93±4.65 135.67±9.86 121.88±12.60 
1mM 115.21±6.49 81.48±5.05 97.90±7.03 205.43±5.50 
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Figure 3.22. Effect of street MA sample 2 on % DNA synthesis. * P˂ 0.05 indicate a significant 
difference from that of the controls. Results were displayed as mean ± SEM. 
 
3.5.4 Effect of street sample 3 MA on DNA proliferation (Table 3.19 and Figure 
3.23) 
At all the selected concentration used, DNA synthesis showed an increase between 24 
and 96hrs (P≤0.0495). The same trend of increase of DNA synthesis was observed 
between 48 and 72hrs (P˂0.025). 
Exposure at 24hrs: The lowest concentration (0.0001 mM) showed suppression in 
DNA synthesis compared to the control, while higher concentrations (0.1-1mM) 
exhibited increase in DNA synthesis (P˂0.05).  
Exposure at 48hrs: Selected concentrations showed similar results to the control 
(P≥0.05) with the exception of (0.001-0.01mM). 
Exposure at 72hrs: With the exception of 0.0001mM, all other selected 
concentrations exhibited a significant increase in DNA synthesis relative to the 
control.  
* 
 
* 
 
* 
 
* 
 
* 
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Exposure at 96hrs: Dose related increase in DNA synthesis occurred at 96hrs where 
the higher concentration (1mM) produce the greater proliferation compare to control.   
Table 3.19: The effect of selected concentrations of street MA sample 3 on DNA synthesis of bEnd5 
cells at various time intervals (Mean ± SEM, n=6) 
Compound 
Time 
Street MA 3 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 84.27±7.52 102.42±7.30 92.80±7.39 139.42±16.17 
0.001mM 102.06±11.46 121.10±2.49 144.41±9.54 139.76±16.72 
0.01mM 134.84±4.71 128.08±7.65 155.84±24.27 162.93±19.45 
0.1mM 115.89±0.65 90.95±6.37 168.86±17.51 163.56±7.45 
1mM 133.65±6.40 94.35±3.44 116.46±8.82 206.67±16.88 
 
 
Figure 3.23. Effect of street MA sample 3 on % DNA synthesis. * P˂ 0.05 indicate a significant 
difference from that of the controls. Results were displayed as mean ± SEM. 
 
 
 
* 
 
* 
 
* 
 
* 
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3.5.5 Effect of street sample 4 MA on DNA proliferation (Table 3.20 and Figure 
3.24) 
Over the period of 24 to 96hrs, MA induced a significant suppression in % DNA 
synthesis (P˂0.05) in contrast to the control.  
Exposure at 24hrs: Significant decrease (P≤0.034) in DNA synthesis was observed 
in all the selected concentrations.  
Exposure at 48hrs: A significant decrease in DNA synthesis was also observed at 
48hrs. 
Exposure at 72hrs: Significant decrease in DNA synthesis was observed in all the 
selected concentrations. 
Exposure at 96hrs: Dose response profile to the sequential increase in the 
concentrations of street MA sample 4 was observed.  
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Table 3.20: The effect of selected concentrations of street MA sample 4 on DNA synthesis of bEnd5 
cells at various time intervals (Mean ± SEM, n=6) 
 
 
Figure 3.24. Effect of street MA sample 4 on % DNA synthesis. * P˂ 0.05 indicate a significant 
difference from that of the controls. Results were displayed as mean ± SEM. 
 
 
 
 
 
Compound 
Time 
Street MA 4 
24 hr 48 hr 72 hr 96 hr 
0.0001mM 41.92±4.24 89.13±9.61 64.10±4.42 40.45±5.81 
0.001mM 58.27±3.995 102.03±8.97 90.31±7.38 56.83±11.58 
0.01mM 71.14±3.97 107.42±3.90 89.72±10.30 74.28±11.65 
0.1mM 64.37±2.40 87.30±8.59 92.67±6.82 82.77±12.90 
1mM 65.24±3.14 85.97±5.72 62.36±3.38 90.50±12.40 
* 
 
* 
 
* 
 
* 
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3.6 Effect of selected concentrations of pure and street MA sample 1 on the 
cell cycles of bEnd5 cells  
 
Flow cytometry is a technique used to measure the properties of individual cells. Flow 
cytometry was used to evaluate the effects of MA on the various stages of the bEnd5 
cell cycle. Pure MA and street MA sample 1 were selected because of their 
experimental profile similarity. [Flow cytometry provides information as to the 
various stages of cells through the process of cell division, M, G1, S and G2 at 
selected time frames of 24, 48, 72, and 96hrs.]   
 
Table 3.21. Effect of pure and street MA sample 1 on phases of the cell cycle at 24hrs (≥ 10000) events 
analysed) 
 
 
 
 
 
 
 
 Cell Cycle phases 
 G1 S G2-M 
Control 45.87 40.39 13.45 
 Pure Street MA Pure Street MA Pure Street MA 
0.1µM 42.96 37.99 51.20 52.37 5.84 9.64 
1µM 41.85 45.84 39.49 36.73 18.66 17.43 
0.01mM 42.99 46.61 39.89 39.58 17.12 13.61 
0.1mM 41.59 44.00 39.77 36.64 18.64 19.36 
1mM 46.40 49.86 40.56 32.30 13.04 17.84 
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Figure 3.25. Relative cell numbers (%) at distinct phases of the cell cycle of bEnd cells exposed to pure 
MA at 24hrs (≥ 10000 events analysed).  
 
 
Figure 3.26 . Relative cell numbers (%) at distinct phases of the cell cycle of bEnd cells exposed to 
street MA 1 at 24hrs (≥ 10000 events analysed).  
 
Table 3.2, Fig 3.25 and Fig. 3.26 showed that at 24hrs, the profiles of the cell cycle to 
pure and street MA sample 1 were remarkably similar. It is clear that for pure and 
street MA 1, the lowest concentration 0.0001mM caused less bEnd5 cells to enter into 
G2-M phase of the cell cycle, elevating cells in S-phase relative to the control. The 
other concentration did not appear to differ from controls.  
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Figure 3.27. The above histograms were acquired using flow cytometry and A) represent results from 
control cells, while, bEnd5 cells treated with varying concentration of pure MA are represented by the 
following histogram after 24hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM 
after 24hrs (≥ 10 000 vents analysed). Note smaller quantity of G2-M cells in B) above. 
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Figure 3.28. These Scatter plots display results obtained using flow cytometry where control cells 
represented by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  
F) 1mM pure MA at 24hrs (≥ 10 000 events analysed). Scatter plots were used to generate histogram 
and the data was tabled and represented as bar graph. R1 representing the population and R2 represent 
single cells identified.  
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Figure 3.29.  The above histograms were acquired using flow cytometry and A) represent results from 
control cells, while, bEnd5 cells treated with varying concentration of street  MA sample 1 are 
represented by the following histogram after 24hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 
0.1mM and F) 1mM after 24hrs (≥ 10000 vents analysed). Note the decrease G2-M number of bEnd5 
cells in B) above.  
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Figure 3.30. These Scatter plots display results obtained using flow cytometry where control cells 
represented by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  
F) 1mM street MA sample 1 at 24hrs (≥ 10000 events analysed). Scatter plots were used to generate 
histogram and the data was tabled and represented as bar graph. R1 representing the population and R2 
represent single cells identified.  
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Table 3.22. Effect of pure and street MA sample 1 on phases of the cell cycle at 48hrs (≥ 10000 events 
analysed) 
 
 
Figure 3.31. Relative cell numbers (%) at distinct phases of the cell cycle for pure MA at 48hrs of 
exposure. 
 
 Cell cycle phases 
 G1 S G2-M 
Control 40.91 43.94 15.15 
 Pure Street MA Pure Street MA Pure Street MA 
0.1µM 45.77 53.03 40.07 35.64 14.16 11.32 
1µM 42.43 55.59 42.25 34.34 15.32 10.07 
0.01mM 45.01 50.85 42.63 38.06 12.36 13.1 
0.1mM 44.38 49.67 38.19 38.42 17.43 11.9 
1mM 38.34 55.85 38.12 35.93 23.54 8.22 
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Figure 3.32. Relative cell numbers (%) at distinct phases of the cell cycle for street MA sample 1 at 
48hrs of exposure. (See supporting histrogarms and scatter plots on appendix A-D). 
 
Table 3.22, Fig.3.31 and Fig.3.32 demonstrated that after 48hrs, 0.1mM and 1mM 
concentrations of pure MA resulted in less cells occupying S phase, resulting in more 
cells entering the following stages (G2-M) at these concentrations. Street MA sample 
1 displayed a difference to that of pure MA, here the G0-G1 phase was elevated 
relative to the control which indicated less cells entering into the S phase, which 
resulted in the decrease number of cells observed in G2-M phase.  
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Table 3.23. Effect of pure and street MA sample 1 on phases of the cell cycle at 72hrs (≥ 10000 events 
analysed). 
 
 Cell cycle phases 
 G1 S G2-M 
Control 46.36 43.15 10.48 
 Pure Street MA Pure Street MA Pure Street MA 
0.1µM 56.17 53.03 34.66 35.64 9.17 11.32 
1µM 49.66 55.59 37.48 34.34 12.86 10.07 
0.01mM 49.86 50.85 38.47 38.06 12.08 13.10 
0.1mM 47.39 49.67 37.87 38.42 14.74 11.90 
1mM 56.36 54.88 39.21 35.16 4.42 9.96 
 
 
Figure 3.33. Relative cell numbers (%) at distinct phases of the cell cycle for pure MA at 72hrs of 
exposure. 
 
Figure 3.34. Relative cell numbers (%) at distinct phases of the cell cycle for street MA at 72hrs of 
exposure. (See supporting histrogarms and scatter plots on appendix E-H). 
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Table 3.2, Fig. 3.37 and Fig.3.38 shows that after 72hrs, profiles of the pure MA and 
street MA sample 1 were very similar: in both experiments MA caused increased 
numbers of cells to enter into G0-G1 phase of the cell cycle relative to the controls. 
This resulted in less cells entering into S phase and also acutely delayed entry of cells 
into the G2-M phase at the higher concentration of MA samples. 
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Table 3.24. Effect of pure and street MA sample 1 on phases of the cell cycle at 96hrs (≥ 10000 events 
analysed). 
 Cell cycle phases 
 G1 S G2-M 
Control 36.75 63.25 0.00 
 Pure Street MA Pure Street MA Pure Street MA 
0.1µM 57.02 63.86 36.38 28.20 6.38 7.94 
1µM 58.45 64.86 37.50 26.49 4.05 8.65 
0.01mM 33.66 44.94 66.34 55.06 0.00 0.00 
0.1mM 58.55 39.48 30.44 60.52 11.02 0.00 
1mM 59.37 57.52 40.63 25.59 0.00 16.89 
 
 
 
Figure 3.35. Relative cell numbers (%) at distinct phases of the cell cycle for pure MA at 96hrs of 
exposure. 
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Figure 3.36. Relative cell numbers (%) at distinct phases of the cell cycle for street MA at 96hrs of 
exposure. (See supporting histrogarms and scatter plots on appendix I-L). 
 
Table 3.24, Fig.3.43 and Fig.3.44 demonstrate that after 96hrs, profiles of pure and 
street MA sample 1 were very similar for the lowest concentrations. Compared to the 
control, bEnd5 cells were observed to be located in G0-G1 phase of the cell cycle 
compare to other phases of the cell cycle for both pure and street MA sample 1. 
Generally, street MA sample 1 had more cells in G0-G1 phase compared to pure MA. 
A small number of cells were obtained in G2-M phase.  
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CHAPTER 4 
 
4.1 Discussion and Conclusion 
 
The blood brain barrier (BBB) is an interface between the circulation and brain 
parenchyma, and is a very restrictive barrier (Shadi et al., 2012). It has dual functions 
which includes the barrier function and regulated transport function (Imola et al., 
2011). The barrier function restricts the transport of potentially toxic or harmful 
substances from the intravascular compartment to the brain, while the regulated 
transport function is responsible for the transport of nutrients to the brain and removal 
of metabolites. The BBB therefore, functions in maintaining the homeostasis of the 
CNS to ensure proper brain function (Ijomone at el., 2011). This barrier is composed 
of endothelial cells that are tightly stitched together by adhesion molecules, adherence 
and TJ proteins (Dietrich., 2009). TJs make up the primary anatomic component of 
the BBB, and acts as a physical barrier; forcing most molecular traffic to take a 
transcellular route, rather than moving paracellularly, as in most cases of endothelia 
(Imola et al., 2011). In this study the effects on the bEnd5 immortalised brain 
endothelial cells from the balb/c mice was used to test the effects of MA and illicit 
MA, (derived from the streets of Cape Town) on their physiological function.   
 
Blood concentration levels can generally be used to distinguish between therapeutic 
and recreational use. Normal concentration of MA in recreational use ranges between 
0.01mg/L to 2.5mg/L in humans. Any concentration that is greater than this represents 
abuse, and could possibly results in toxicity. In this study, 0.0001-0.001mM which is 
 
 
 
 
91 
 
described as normal plasma ranges and 0.1-1mM which were higher than normal 
ranges, were used (Hart et al., 2008).  
In general, results showed that MA did not affect the cell's viability at any of the 
concentrations used at any time intervals. Studies have reported on the neurotoxicity 
of MA (Dietrich., 2009) and it was, therefore expected that MA would decrease the 
bEnd5 cell's viability. However, in this study, the viability of MA exposed cells were  
found to be comparable to controls. Neurotoxicity as a result of MA leads to neuronal 
cell death in several brain areas, including the cortex, striatum, and hippocampus 
(Deng et al., 2001, Martins et al., 2011). Studies have analyzed the effects of MA on 
the BBB in vivo, demonstrating that MA cause an effect on the BBB by increasing 
permeability correlated with the preceding temperature increase induced by MA 
(Martins et al., 2011). 
 
Cell growth % as a result of pure MA exposure decreased over time, with 96hrs 
showing a significant suppression in cell growth when compared to the control. At 
48hrs, the intermediate concentrations (0.01mM and 0.1mM) of pure MA resulted in 
increased growth. Rizzo at el., (2010) proposed that MA induced its effects by 
stimulating metabolic cell growth. Furthermore, it should be noted that physiological 
plasma levels of MA abuse ranges between 0.0001 and 0.01mM (Hart at el., 2008). 
Data obtained from trypan blue assays showed that the bEnd5 cell numbers generally 
increased in the first 24hrs and then decreased over time with the exception of street 
MA sample 3 and 4. Street MA sample 3 data showed that bEnd5 cells growth was 
suppressed across all time intervals, while, street MA sample 4 demonstrated similar 
% cell growth over time compared to the control. This variation in sample effects 
could be due to impurities that may be found in the different street MA preparations, 
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(in the clandestine labs). During the manufacturing of illicit MA in various chemicals 
such as counterintuitive and prescription drugs (e.g. ephedrine) are used, which may 
have led to the different effects observed in the bEnd5 cells. Overall, the cell numbers 
decreased to increased MA doses over time, and displayed a dose-dependent effect 
(see chapter 3 fig 3.10-3.14). Street MA sample 1 also showed a significant elevation 
in % cell growth at 24, 48, and 72hrs followed by a decrease at 96hrs. Although MA 
was not quantified in this study, it can be suggested (based on the similar results 
between pure and street MA sample 1) that street MA sample 1 had comparable purity 
to the certified pure MA purchased from Sigma (Fig 3.10 and 3.11).  
 
In contrast, 0.01mM and 0.1mM of street MA sample 2 resulted in suppression of % 
cell growth over 24hrs, and thereafter, the bEnd5 cells appeared to recover. Overall, 
% cell growth of street MA sample 4 was similar over time, with respect to the 
different concentrations. MA suppressed the growth of cells but it did not affect their 
viability compared to control. Studies by Bowyer et al., (2006) showed the effect of 
MA on BBB functioning, in which leakage was observed across the barrier in the 
cerebral cortex of mice. This were also observed at high concentrations of MA 
causing disruption in the limbic system, and produced neuronal degeneration of 
mouse BBB (Bowyer et al, 2006). It can thus be inferred that MA interferes with the 
bEnd5 cell cycles since it interrupts these critical phases which could results in 
decrease cell division without affecting viability. It is clear from the results reported 
in this study that MA caused the suppression of cell growth, while not affecting their 
viability. These findings are supported by the work performed by Yuan et al (2011), 
who found that MA is, indeed, associated with a long-term exposure in BBB cells 
without specific modification in S-phase of the cell cycle.  
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Burrows et al. (2000) reported, that an increase in  metabolic stress causes 
compromised energy production and has thus been thought to contribute to lasting 
changes in the neurotransmitter systems following high-doses of MA. Adenosine 
triphosphate (ATP) which is predominantly used by the cell for various functions is 
produced by the  mitochondria (Riddle et al., 2008). In the current study cell viability 
did not show significant differences at selected MA concentration over the observed 
time intervals relative to the controls. Based on these findings the production of ATP 
by the bEnd5 cells was investigated to determine whether the division of endothelial 
cells were compromised by a lack of ATP production; metabolic status of a cell being 
crucial for cell division (Wallace., 2005). The ATP levels produced by bEnd5 cells 
treated with selected MA concentrations were similar to that of the control at 24hrs 
followed by a significant increase by 96hrs (chapter 3.3). The elevation of ATP level 
observed at 96hrs might be a mechanism by which bEnd5 cells are trying to 
compensate for the inhibited cell growth observed, thus, producing more ATP in 
preparation of the next phase which has been blocked by MA. Viable cells require 
energy to function and divide. The various concentrations of MA analysed showed no 
effect on the ATP levels at 24, 48 and 72hrs when compared to control.  
 
Research performed on bEnd5 cells, investigating mitochondrial activity, showed that  
a mitochondrial checkpoint exists in late G1 phase, where low ATP prompts the 
activation of an AMPK–p53–cyclin E-dependent pathway (Marisa et al., 2010). The 
low ATP may trigger a G1-S phase check point that involves the sequential activation 
of AMPK and p53, and ultimately the down-regulation of cyclin E levels. Activation 
of AMPK by impaired mitochondria activates p53 and leads to a decrease in cyciln E 
level, which could result in a block in the G1-S phases (Finke et al., 2009). Triggering 
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of this pathway may possibly arrest metabolically impaired cells low ATP production 
instead of committing them to cell division. Mitochondria use energy pathways such 
as the citric acid cycle and electron transport chain (ETC), to produce ATP. Marisa et 
al., (2010) showed that MA inhibits the ETC and up-regulates many ETC inhibitors 
such as complex IV via the activation of cytochrome oxidase. Consequently, these 
high doses of MA and activation of cytochrome oxidase increases reactive species, 
resulting in dopaminergic neurotoxicity (Burrowe et al., 2000). ETC inhibitors are 
therefore strongly implicated in mitochondrial dysfunction and are thought to be 
linked in the mechanism of MA induced neurotoxicity. This premise is supported by 
studies which illustrate that  energetic stress caused by administration of a citric acid 
cycle inhibitor, exacerbates the persistent dopaminergic deficits caused by MA 
(Riddle et al., 2006).  
 
In this study it was demonstrated that at 96hrs, cell numbers were significantly lower 
than that of controls. It was also noted that during this time interval, the ATP levels 
were significantly elevated compared to controls. This could be an indication that 
cells exposed to MA have sufficient ATP available for cell division, but their ability 
to use the energy source is blocked by an unknown mechanism. This predicts a 
possible connection between the decrease in cell growth and increase ATP levels at 
96hrs. It can, therefore, be proposed that the increase in ATP is a mechanism by 
which bEnd5 cells attempt to compensate for the inhibited cell growth. This study's 
findings also suggest that the suppression in cell growth may be caused by the 
inability of bEnd5 cells to efficiently use ATP at 96hrs, and thus MA and/or its 
metabolites may be directly or indirectly impairing the cells ability to utilize ATP. 
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In order to investigate whether the suppression of bEnd5 cell numbers at 96hrs was 
due to changes in DNA production, DNA synthesis levels were analysed using BrdU 
incorporation. The selected concentrations used to determine DNA synthesis analysis 
was the same as those selected for the assays previously performed. The bEnd5 cells 
showed variation in their levels of BrdU incorporation, in which DNA synthesis was 
suppressed at 96hrs for pure and street MA sample 4 when compared to controls, 
while street MA sample 1 showed similar results to that of controls. Street MA 
sample 2 and 3 however, showed higher DNA synthesis than that of the control, with 
street MA sample 3 producing higher levels of DNA compared to all other MA 
samples. This distinct variation in which the different MA samples affect DNA levels 
might be due to the additional molecular components (Figure 3.1-3.4) found in the 
samples as a result of the illicit methods used to produce MA. This study showed that 
viability of bEnd5 cells exposed to MA were not affected, while cell growth was 
suppressed and accompanied by an increase in ATP at 96hrs. Overall DNA synthesis 
increased between 24 and 96hrs, however, the DNA levels for pure and street MA 
sample 4 did not exceed that of the controls. The increase in DNA levels observed 
compared to the decrease in cell numbers may be because the bEnd5 cells are able to 
generate enough DNA in preparation for division in the M phase, but are perhaps 
blocked at the G0-G1 stage of the cell cycle. This indicates that the suppression 
observed may be due to a mechanism that blocks the progression of cell division. To 
date, there are no reports investigating the effects of MA on the cell cycles of a 
monolayer of bEnd5 cells.  
 
The results of this study suggest that MA slows down the proliferation of the bEnd5 
cells by targeting a specific phase of the cell cycle. Normal cells undergo growth 
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phases in order to maintain survival in all living organisms. Cell growth and division 
is determined by a successful cell cycle which involves alterations within the cell in 
order to proliferate, repair or segregate the genome (Chaw et al., 2010). The stages of 
the cell cycle are regulated by a control system that governs progression through the 
cell cycle (Bruce et al., 2007).  
 
As the cell cycle is an important component of viability (Del Bin et al., 1991), we 
therefore looked at the effect of MA on the various stages (G1, G2, S and M phases).  
At 24 and 48hrs MA exposure showed no effect on the cell cycle phases when 
compared to the controls. This argument is supported by the study performed by Yuan 
et al., (2011) which showed that MA had an effect only after an extended period 
(6hrs/day: 4-13days) of exposure without changing dynamics of the cell cycle stages. 
It is important to note that the significant changes in bEnd5 cell cycles were observed 
at 72 and 96hrs, which further aligns with the findings of Yuan et al., (2011). MA 
exposure at 72 and 96hrs resulted in cell cycle arrest at G0-G1and G2-S phase (Fig: 
3.33, 3.34, 3.35 and 3.36). 
 
Using in vitro BrdU assays coupled to the analysis of cell cycle progression, this 
study illustrated that although MA affected the levels of DNA synthesis differently, it 
led to a specific G1-S phase arrest. Thus, long term exposure to MA impedes bEnd5 
cell proliferation which could be detrimental to the integrity of the BBB and 
ultimately the homeostasis of the CNS.  
 
The slight differences observed in the assays performed could be due to impurities 
used in the manufacturing of illicit MA and the quality of MA found in these samples.  
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In conclusion, it was surprising to observe that the viability of bEnd5 cells exposed to 
MA was unaffected and that MA did not appear to be toxic to the bEnd5 cells at the 
selected concentrations used. MA however, impeded cell growth over a period of 
96hrs when compared to the controls, which may have resulted in an increase in ATP 
production. While DNA synthesis showed differences in their levels with respect to 
the various MA samples at 96hrs, cell cycle analysis demonstrated that the bEnd5 
cells were arrested at the G1-S phase between 72 and 96hrs. The findings of this study 
therefore suggests that although the highly soluble compound MA permeates through 
all brain tissue leading to significant neurotoxicity, it surprisingly showed no toxic 
effects on the endothelial cells of the in vitro BBB. There seems to be yet undescribe 
mechanism whereby MA brings about its negative effects, not only in the endothelial 
cells but also in the neural of the brain (Yuan et al., 2011).  
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CHAPTER 5 
 
5.1 Future Perspectives 
 
Future studies should attempt to elucidate the mechanism whereby MA affects the cell 
cycles, by specifically analysing cell cycle phase lengths and also identifying at which 
stage in these phases MA interferes. Moreover, it is acknowledged that cell cycle 
analysis in this study was not performed on a population of cells that were 
synchronized, and therefore this must also be included in the future approaches. Since 
it is evident that MA interferes with the energy metabolism of the cells, further 
investigations into the electron transport chain as well as the tricarboxy acid cycle are 
required. 
 
Little is known about the effects of psychoactive drugs on the BBB structure and 
function, thus studies should also focus on the pathways involved in maintaining the 
physical integrity of the BBB by analysing the expression of important regulatory 
proteins such as the tight junction and adherens proteins. 
 
Furthermore, understanding the bioavailability of MA in the bEnd5 cells may also 
shed light on the degree of interference MA may have on the cell cycles, since it 
seems that long-term exposure and presence of MA has greater adverse effects.  
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APPENDIX A-L 
 
 C D
 
Appendix A. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration of pure MA are represented by the following 
histogram after 48hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 48hrs (≥ 10000 
vents analysed).  
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Appendix B. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM pure MA 
at 24hrs (≥ 10000 events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. R1 representing the population and R2 represent single cells identified.  
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Appendix C. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration of street MA sample 1are represented by the 
following histogram after 48hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 48hrs 
(≥ 10000 vents analysed 
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Appendix D. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM street  MA 
sample 1 at 48hrs (≥ 10000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. R1 representing the population and R2 represent single cells identified  
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Appendix E. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration pure MA are represented by the following histogram 
after 72hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 72hrs (≥ 10000 vents 
analysed).  
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Appendix F. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM pure MA 
at 72hrs (≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. R1 representing the population and R2 represent single cells identified.  
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Appendix G. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration of street  MA sample 1 are represented by the 
following histogram after 72hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 72hrs 
(≥ 10000 events analysed).  
 
 
 
 
 
118 
 
 
 A B
 C D
 E F
 
Appendix H. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM street MA  
sample 1 at 72hrs (≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was 
tabled and represented as bar graph. R1 representing the population and R2 represent single cells identified.  
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Appendix I. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration of pure MA are represented by the following 
histogram after 96hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 96hrs (≥ 10000 
vents analysed).  
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Appendix J. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM pure MA 
at 96hrs (≥ 10 000 events analysed). Scatter plots were used to generate histogram and the data was tabled and 
represented as bar graph. R1 representing the population and R2 represent single cells identified.  
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Appendix K. The above histograms were acquired using flow cytometry and A) represent results from control 
cells, while, bEnd5 cells treated with varying concentration of street  MA sample 1 are represented by the 
following histogram after 96hrs: B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and F) 1mM after 96hrs 
(≥ 10000 vents analysed).  
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Appendix L. These Scatter plots display results obtained using flow cytometry where control cells represented 
by A) and bEnd5 cells exposed to B) 0.0001mM, C) 0.001mM, D) 0.01mM, E) 0.1mM and  F) 1mM street MA 
sample 1 at 96hrs (≥ 10 000 events analysed). R1 representing the population and R2 represent single cells 
identified. Scatter plots were used to generate histogram and the data was tabled and represented as bar graph. 
R1 representing the population and R2 represent single cells identified.  
 
 
 
 
 
 
 
